Processing 00000000.tx.1: Presenilin 1Regulates Pharmacologically Distinct -Secretase Activities IMPLICATIONS FOR THE ROLE OF PRESENILIN IN -SECRETASE CLEAVAGE* M. 

Phrase: "Presenilin 1Regulates Pharmacologically Distinct -Secretase Activities IMPLICATIONS FOR THE ROLE"

Phrase: "OF PRESENILIN IN -SECRETASE CLEAVAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "* M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Paul Murphy, Sacha N. 

Phrase: "Paul Murphy,"

Phrase: "Sacha N."
Processing 00000000.tx.3: Uljon, Paul E. 

Phrase: "Uljon,"

Phrase: "Paul E."
Processing 00000000.tx.4: Fraser, Abdul Fauq, Hilary A. 

Phrase: "Fraser,"

Phrase: "Abdul Fauq,"

Phrase: "Hilary A."
Processing 00000000.tx.5: Lookingbill, Kirk A. 

Phrase: "Lookingbill,"

Phrase: "Kirk A."
Processing 00000000.tx.6: Findlay, Tawnya E. 

Phrase: "Findlay,"

Phrase: "Tawnya E."
Processing 00000000.tx.7: Smith, Patrick A. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "Patrick A."
Processing 00000000.tx.8: Lewis, D. 

Phrase: "Lewis,"

Phrase: "D."
Processing 00000000.tx.9: Chris McLendon, Rong Wang, and Todd E. 

Phrase: "Chris McLendon,"

Phrase: "Rong Wang,"

Phrase: "and"

Phrase: "Todd E."
Processing 00000000.tx.10: Golde** From the Mayo Clinic Jacksonville, Department of Pharmacology, Jacksonville, Florida 32224,The Rockefeller University, Laboratory for Mass Spectrometry, New York, New York 10021,and The University of Toronto, Tanz Neuroscience Building, 6Queen's Park Crescent, Toronto, Ontario M5S 3H2, Canada Received for publication, April 3,2000, and in revised form, May 10,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Presenilins (PSs) are polytopic membrane proteins that have been implicated as potential therapeutic targets in Alzheimer's disease because of their role in regulating the -secretase cleavage that generates the amyloid protein (A). 

Phrase: "Golde"

Phrase: "*"

Phrase: "*"

Phrase: "From the Mayo Clinic Jacksonville,"

Phrase: "Department of Pharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Jacksonville,"

Phrase: "Florida 32224,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016253:Florida [Geographic Area]

Phrase: "The Rockefeller University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Laboratory for Mass Spectrometry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10021,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "and"

Phrase: "The University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tanz Neuroscience Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547706:Building [Functional Concept]
   827   C1999269:Building [Manufactured Object]

Phrase: "6Queen's Park Crescent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444628:crescent [Spatial Concept]

Phrase: "Toronto,"

Phrase: "Ontario M5S 3H2,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "April 3,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "May 10,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Presenilins (PSs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "polytopic membrane proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "implicated as potential therapeutic targets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0302350:Therapeutic [Functional Concept]
   760   C3245505:Potential [Qualitative Concept]
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "because of their role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating"

Phrase: "the -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "that"

Phrase: "generates"

Phrase: "the amyloid protein (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.11: It is not clear how PSs regulate -secretase cleavage, but there is evidence that PSs could be either essential cofactors in the -secretase cleavage, -secretase themselves, or regulators of intracellular trafficking that indirectly influence -secretase cleavage. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "how PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "regulate -"

Phrase: "secretase cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "but"

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "be"

Phrase: "either essential cofactors in the -secretase cleavage, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178555:cofactors [Biologically Active Substance]

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "themselves,"

Phrase: "or"

Phrase: "regulators of intracellular"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0182953:regulators [Medical Device]
   756 E C1704734:Regulator [Medical Device]
   756 E C1704735:Regulator [Conceptual Entity]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "that indirectly"

Phrase: "influence -"

Phrase: "secretase cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.12: Using presenilin 1(PS1) mutants that inhibit A production in conjunction with transmembrane domain mutants of the amyloid protein precursor that are cleaved by pharmacologically distinct -secretases, we show that PS1 regulates multiple pharmacologically distinct -secretase activities as well as inducible -secretase activity. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A production in conjunction with transmembrane domain mutants of the amyloid protein precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0033268:production [Occupational Activity]

Phrase: "that"

Phrase: "are"

Phrase: "cleaved by pharmacologically distinct -secretases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "regulates"

Phrase: "multiple pharmacologically distinct -secretase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441655:Activities [Activity]
   771 E C0205177:Activity [Functional Concept]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]

Phrase: "as well as"

Phrase: "inducible -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.13: It is likely that PS1 acts indirectly to regulate these activities (as in a trafficking or chaperone role), because these data indicate that for PS1 to be -secretase it must either have multiple active sites or exist in a variety of catalytically active forms that are altered to an equivalent extent by the mutations we have studied.  

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "indirectly to"

Phrase: "regulate"

Phrase: "these activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "as in a"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "or"

Phrase: "chaperone role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that for PS1 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]

Phrase: "be -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "it"

Phrase: "must"

Phrase: "either"

Phrase: "have"

Phrase: "multiple active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0205681:Sites, Active [Functional Concept]
   827   C0205145:Sites [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "exist in a variety of catalytically active forms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0205177:Active [Functional Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   744   C2987476:Exist [Conceptual Entity]
   711 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "altered to an equivalent extent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0392747:Altered [Functional Concept]
   760   C0439185:equivalent [Quantitative Concept]
   760   C0439792:Extent [Spatial Concept]

Phrase: "by the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "have"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The 4-kDa amyloid protein (A)1 deposited in Alzheimer's disease (AD) is a normally secreted proteolytic product of the amyloid protein precursor (APP) (1-3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The 4-kDa amyloid protein (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   840   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "deposited in Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0333562:deposited [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "a normally"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "proteolytic product of the amyloid protein precursor (APP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Generation of A from APP requires two sequential proteolytic events: an initial cleavage at the amino terminus of the A sequence referred to as -secretase (4) and a subsequent cleavage at the carboxyl terminus known as -secretase. 

Phrase: "Generation of A from APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "requires"

Phrase: "two sequential proteolytic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: ":"

Phrase: "an initial cleavage at the amino terminus of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "A sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(4"

Phrase: ")"

Phrase: "and"

Phrase: "a subsequent cleavage at the carboxyl terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "as -secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.16: Recently, a membrane-bound aspartic protease has been implicated as a -secretase (5-8). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a membrane-bound aspartic protease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "implicated as a -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: However, the protease(s) responsible for -secretase cleavage have not been identified. 

Phrase: "However,"

Phrase: "the protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "responsible for -secretase cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.18: In addition, a third proteolytic activity referred to as -secretase cleaves within the A sequence to release a large secreted derivative (sAPP), thus precluding formation of full-length A. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a third proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1561536:*Activity [Idea or Concept]
   827   C1947941:proteolytic [Enzyme]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves within the"

Phrase: "A sequence to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a large secreted derivative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527240:Derivative [Functional Concept]

Phrase: "(sAPP"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "precluding"

Phrase: "formation of full-length A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.19: In mammalian cells, at least two members of the ADAM family (a disintegrin and metalloprotease) can contribute to the -secretase activity (9, 10). 

Phrase: "In mammalian cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "at least two members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680022:members [Population Group]
   793 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the ADAM family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "(a disintegrin and metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "can"

Phrase: "contribute to the -secretase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   760   C1880177:Contribute [Activity]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.20: Although full-length APP is not cleaved by -secretase, APP carboxyl-terminal fragments (CTF) generated through cleavage of APP by either - or -secretase are both substrates for -secretase, with cleavage of CTF releasing a peptide referred to as p3 (A17-40 or A17-42) (1-3). 

Phrase: "Although"

Phrase: "full-length APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cleaved by -secretase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]

Phrase: "APP carboxyl-terminal fragments (CTF)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated through cleavage of APP"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   800 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0010813:cleavage [Cell Function]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1330957:cleavage [Cell Function]
   748   C1709634:Precursor [Idea or Concept]
   748   C3146294:Generated [Activity]

Phrase: "by either - or -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "both substrates for -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "with cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "of CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "p3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "(A17-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439509:/40 [Temporal Concept]
   861   C1548682:A17 [Intellectual Product]

Phrase: "or"

Phrase: "A17-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1548682:A17 [Intellectual Product]

Phrase: ")"

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: -Secretase-catalyzed cleavages are of particular interest for a number of reasons. 

Phrase: "-Secretase-catalyzed cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0010813:cleavage [Cell Function]
   793   C0596311:Cleavage [Phenomenon or Process]
   793   C1330957:cleavage [Cell Function]

Phrase: "are of particular interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C1551058:Are [Quantitative Concept]

Phrase: "for a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.22: First, they are unusual in that the cleavage site of the substrate is predicted to lie within the transmembrane domain (TMD). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "they"

Phrase: "are"

Phrase: "unusual in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2700116:Unusual [Qualitative Concept]

Phrase: "that"

Phrase: "the cleavage site of the substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lie within the transmembrane domain (TMD)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1519623:Transmembrane Domain [Amino Acid Sequence]
   760   C1167322:transmembrane [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C2752508:transmembrane [Cell Component]
   760   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.23: Rather than primary amino acid sequence, position of the -cleavage site with respect to the membrane appears to be the prime determinant of cleavage, with the length of the luminal TMD determining that position (11). 

Phrase: "Rather than"

Phrase: "primary amino acid sequence,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   923   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   923   C0682967:primary aminoacid [Amino Acid, Peptide, or Protein]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0202406:Acid [Laboratory Procedure]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "position of the -cleavage site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:Position [Spatial Concept]

Phrase: "with respect to the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the prime determinant of cleavage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521761:Determinant [Functional Concept]

Phrase: "with the length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "of the luminal TMD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C2752508:transmembrane [Cell Component]
   827   C3541951:Domain [Intellectual Product]

Phrase: "determining"

Phrase: "that position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.24: Whether -secretase actually cleaves residues within the membrane is a controversial topic. 

Phrase: "Whether -"

Phrase: "secretase actually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "residues within the membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "is"

Phrase: "a controversial topic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1522168:TOPIC [Functional Concept]
   861   C1555712:topic [Idea or Concept]
   789 E C0332237:Topical [Spatial Concept]
Processing 00000000.tx.25: To date, there is no definitive evidence showing that any protease can cleave bonds when they are buried within a TMD. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "there"

Phrase: "is"

Phrase: "no definitive evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "any protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "can"

Phrase: "cleave"

Phrase: "bonds"

Phrase: "when"

Phrase: "they"

Phrase: "are"

Phrase: "buried within a TMD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1519623:Transmembrane Domain [Amino Acid Sequence]
   760   C1167322:transmembrane [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C2752508:transmembrane [Cell Component]
   760   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.26: Second, altered -secretase cleavage is implicated in the development of AD (reviewed in Ref. 12). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "altered -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "implicated in the development of AD ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "reviewed in Ref. 12"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.27: FAD-linked mutations in APP, presenilin 1(PS1), and PS2 alter -secretase activity by increasing the amount of a minor A species, the more amyloidogenic A42, without significantly altering total A production. 

Phrase: "FAD-linked mutations in APP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PS2"

Phrase: "alter -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "secretase activity by increasing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0474395:increased activity [Finding]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "the amount of a minor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "A species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "the more amyloidogenic A42,"

Phrase: "without significantly"

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.28: Significantly, both PS1 knockout and presenilin aspartate mutants decrease -secretase cleavage, but it is not known if this is a direct or indirect effect (13-15). 

Phrase: "Significantly,"

Phrase: "both PS1 knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "and"

Phrase: "presenilin aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "decrease -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "secretase cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "if"

Phrase: "this"

Phrase: "is"

Phrase: "a direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "indirect effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(13-15"

Phrase: ")."
Processing 00000000.tx.29: Third, APP CTF are not the only substrate for -secretase activity: CTF generated after ligand-induced cleavage of the extracellular domain of Notch are cleaved at residues near the cytoplasm/membrane junction by a -secretase-like activity (16-18). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "APP CTF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the only substrate for -secretase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated after ligand-induced cleavage of the extracellular domain of Notch"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C1517050:Extracellular Domain [Spatial Concept]
   754   C1749388:Notch ligand [Molecular Function]
   738   C0010813:cleavage [Cell Function]
   738   C0023688:Ligand [Chemical]
   738   C0205263:Induced [Functional Concept]
   738   C0521119:Extracellular [Cell Component]
   738   C0596311:Cleavage [Phenomenon or Process]
   738   C1235660:Notch [Body Space or Junction]
   738   C1330957:cleavage [Cell Function]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3146294:Generated [Activity]
   738   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "cleaved at residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]
   756   C1709915:Residue [Conceptual Entity]
   756   C1882936:RESIDUE [Phenomenon or Process]
   706 E C1609982:Residual [Qualitative Concept]

Phrase: "near the cytoplasm/membrane junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205144:Junction [Spatial Concept]
   827   C1706311:Junction [Medical Device]

Phrase: "by a -secretase-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.30: Significantly, this -secretase activity appears necessary for Notch signaling and also appears to be regulated by PSs. 

Phrase: "Significantly,"

Phrase: "this -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "necessary for Notch signaling"

Phrase: "and"

Phrase: "also"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "regulated by PSs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.31: Finally, because -secretase cleavage is the final step in the generation of A, it remains a major therapeutic target for strategies designed to lower A production. 

Phrase: "Finally,"

Phrase: "because -"

Phrase: "secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "the final step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the generation of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "it"

Phrase: "remains"

Phrase: "a major therapeutic target for strategies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.32: Thus, -secretase is not only an unusual proteolytic activity, but its activity has important biological consequences both with respect to the pathogenesis and treatment of AD and for cell biology in general. 

Phrase: "Thus, -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "an unusual proteolytic activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1561536:*Activity [Idea or Concept]
   827   C1947941:proteolytic [Enzyme]

Phrase: "but"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "important biological consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0686907:consequences [Functional Concept]

Phrase: "both with respect to the pathogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0238767:Both [Spatial Concept]
   753   C0543483:pathogenesis [Functional Concept]
   753   C0679133:respect [Social Behavior]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "treatment of AD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "and for cell biology"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   770   C0005532:Biology [Biomedical Occupation or Discipline]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1515981:And [Idea or Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "in general."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]
Processing 00000000.tx.33: Many disparate roles have been hypothesized to account for the observed effects of PSs on -secretase cleavage. 

Phrase: "Many disparate roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for the observed effects of PSs on -secretase cleavage."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0010813:cleavage [Cell Function]
   739   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   739   C1280500:effects [Qualitative Concept]
   739   C1330957:cleavage [Cell Function]
   739   C1441672:Observed [Functional Concept]
   739   C1551359:account [Idea or Concept]
   739   C2741673:Account # [Clinical Attribute]
   739   C2981730:Account [Classification]
   706 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.34: Recent studies of -secretase activity in cells derived from PS1 knockout mice have implicated PS1 in the regulation of intracellular trafficking (19), as cofactors for -secretase activity (13), or as -secretases themselves (14). 

Phrase: "Recent studies of -secretase activity in cells"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C2348552:Study Activity [Research Activity]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   721 E C2347179:Active Study [Functional Concept]

Phrase: "derived from PS1 knockout mice"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0206745:Knock-out Mice [Mammal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1418985:PS1 [Gene or Genome]
   760   C1441547:Derived [Qualitative Concept]
   760   C1522225:Knock-out [Experimental Model of Disease]
   760   C2986918:PS1 [Gene or Genome]
   760   C3245521:derived [Idea or Concept]

Phrase: "have"

Phrase: "implicated PS1 in the regulation of intracellular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1418985:PS1 [Gene or Genome]
   748   C2986918:PS1 [Gene or Genome]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "cofactors for -secretase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178555:cofactors [Biologically Active Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "as -secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "themselves"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.35: The latter notion that PSs may be -secretase gained further support from studies demonstrating that mutation of either of two aspartate residues potentially lying in opposing transmembrane domains in both PS1 and PS2 decrease -secretase activity, presumably through a dominant negative mechanism (14, 15). 

Phrase: "The latter notion"

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "be -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "gained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   966   C1517378:Gain [Quantitative Concept]
   928 E C0205217:Increased [Quantitative Concept]
   928 E C0439661:Acquired [Temporal Concept]
   928 E C0442805:Increase [Functional Concept]
   928 E C0442808:Increasing [Functional Concept]
   928 E C1301820:Obtain [Functional Concept]
   928 E C1706701:Acquire [Activity]
   928 E C3245488:acquired [Intellectual Product]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support from studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0183683:Support [Medical Device]
   790   C0947630:studies [Laboratory Procedure]
   790   C1521721:Support [Conceptual Entity]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "demonstrating"

Phrase: "that mutation of either of two aspartate residues potentially lying in opposing transmembrane domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0026882:Mutation [Genetic Function]
   734   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in both PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 decrease -secretase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "presumably through a dominant negative mechanism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.36: It was thus proposed that PSs may be novel intramembranous proteases with the aspartates functioning as the catalytic residues; 

Phrase: "It"

Phrase: "was"

Phrase: "thus"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "be"

Phrase: "novel intramembranous proteases with the aspartates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1947941:Proteases [Enzyme]
   750   C2717969:aspartate protease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functioning as the catalytic residues"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007382:Catalytic [Natural Phenomenon or Process]
   760   C0542341:functioning [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.37: alternatively, PSs may function as di-aspartyl cofactors for -secretase activity (14). 

Phrase: "alternatively,"

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "function as di-aspartyl cofactors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0031843:function [Physiologic Function]
   760   C0178555:cofactors [Biologically Active Substance]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   760   C3538902:DI [Gene or Genome]
   760   C3541881:DI [Idea or Concept]

Phrase: "for -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.38: Consistent with this hypothesis, treatment of cultured cells with either pepstatin (11), a prototypic aspartyl protease inhibitor, or a difluoroketone compound, which inhibits aspartyl proteases (20), reduces A production to a similar extent as seen in PS1 knockout cell lines. 

Phrase: "Consistent with this hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "treatment of cultured cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with either pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "a prototypic aspartyl protease inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   861   C0078989:aspartyl protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2717969:Aspartyl Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3536890:Protease Inhibitor [Pharmacologic Substance]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "a difluoroketone compound,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "which"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aspartyl proteases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0078989:aspartyl proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2717969:Aspartyl Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "reduces"

Phrase: "A production to a similar extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "seen in PS1 knockout cell lines."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0205397:Seen [Qualitative Concept]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0560617:knock out [Injury or Poisoning]
   753   C1269647:Cell [Cell]
   753   C1418985:PS1 [Gene or Genome]
   753   C1522225:Knock-out [Experimental Model of Disease]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2986918:PS1 [Gene or Genome]
   719 E C0042789:see [Organism Function]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719 E C1947903:See [Activity]
Processing 00000000.tx.39: However, in all of these cases A production is not completely abolished, indicating that more than one protease likely contributes to -secretase-catalyzed cleavages, a notion suggested by numerous studies showing differential inhibition of the -40 and -42 activities (Refs. 11, 21-24, and this study). 

Phrase: "However,"

Phrase: "in all"

Phrase: "of these cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "abolished"

Phrase: ","

Phrase: "indicating"

Phrase: "that more than one protease likely"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0205447:One [Quantitative Concept]
   753   C0332148:Likely [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]
   753   C1947941:Protease [Enzyme]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to -secretase-catalyzed cleavages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0010813:cleavage [Cell Function]
   779   C0596311:Cleavage [Phenomenon or Process]
   779   C1330957:cleavage [Cell Function]

Phrase: "a notion"

Phrase: "suggested by numerous studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439064:Numerous [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737   C1705535:Suggest [Idea or Concept]
   737 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "differential inhibition of the -40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and -"

Phrase: "42 activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "(Refs. 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "21-24,"

Phrase: "and"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.40: Because -secretase is one of the major therapeutic targets in AD, it is essential to determine whether PSs are -secretases or whether they alter -secretase activity in some other fashion. 

Phrase: "Because -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "one of the major therapeutic targets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in AD,"

Phrase: "it"

Phrase: "is"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are -"

Phrase: "secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "whether"

Phrase: "they"

Phrase: "alter -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "secretase activity in some"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "other fashion."
Processing 00000000.tx.41: It has been pointed out that one of the major problems with the "PSs-as--secretases" hypothesis is the discrepancy between the predominantly ER localization of PSs and the subcellular sites of the majority of -secretase activity in the more distal secretory pathway (Golgi) and endosomal system (25). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that one of the major problems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "with the ""PSs-as--secretases"" hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "the discrepancy between the predominantly ER localization of PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1290905:Discrepancy [Finding]

Phrase: "and"

Phrase: "the subcellular sites of the majority of -secretase activity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   726   C0205681:Sites, Active [Functional Concept]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "in the more distal secretory pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1159342:Secretory Pathway [Cell Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "(Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "endosomal system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.42: In this study, we illustrate another aspect of presenilin regulation of -secretase whereby PS1 appears to regulate multiple pharmacologically and spatially distinct -secretase activities as well as inducible -secretase activity. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "illustrate"

Phrase: "another aspect of presenilin regulation of -secretase whereby PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1547011:Aspect [Quantitative Concept]
   742   C1879746:Aspect [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "multiple pharmacologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439064:Multiple [Quantitative Concept]

Phrase: "and"

Phrase: "spatially distinct -secretase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "as well as"

Phrase: "inducible -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.43: The major implication of these observations is that PS1 either functions indirectly to regulate these activities (as in a trafficking or chaperone role), or, if PS1 is a -secretase, it must have multiple active sites or exist in a variety of catalytically active forms that are altered to an equivalent extent by the mutations we have studied.  

Phrase: "The major implication of these observations"

Phrase: "is"

Phrase: "that PS1 either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "indirectly to"

Phrase: "regulate"

Phrase: "these activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "as in a"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "or"

Phrase: "chaperone role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: ","

Phrase: "if"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "a -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "it"

Phrase: "must"

Phrase: "have"

Phrase: "multiple active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0205681:Sites, Active [Functional Concept]
   827   C0205145:Sites [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "exist in a variety of catalytically active forms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0205177:Active [Functional Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   744   C2987476:Exist [Conceptual Entity]
   711 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "altered to an equivalent extent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0392747:Altered [Functional Concept]
   760   C0439185:equivalent [Quantitative Concept]
   760   C0439792:Extent [Spatial Concept]

Phrase: "by the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "have"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.44: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Inhibitor Synthesis-- Boc-Gly-Val-Val-CHO was synthesized using standard peptide bond-forming reactions. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitor Synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "--"

Phrase: "Boc-Gly-Val-Val-CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0018555:Chinese Hamster [Mammal]
   795   C0008120:chinese [Language]
   795   C0018557:Hamster [Mammal]
   795   C0029939:Ovary [Body Part, Organ, or Organ Component]
   795   C0152035:Chinese [Population Group]
   795   C0227898:ovary [Body Part, Organ, or Organ Component]
   795   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard peptide bond-forming reactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0443286:Reaction [Functional Concept]
   771   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.45: Thus, the dipeptide Boc-Gly-Val-OBn (made by BOP/HOBt/DIEA/DMF-mediated coupling of Boc-Gly-OH with H-Val-OBn) was saponified and then coupled with the Weinreb valine amide (H-Val-(OMe)(Me), Aldrich) using BOP/HOBt/DIEA/DMF to yield the Weinreb tripeptide Boc-Gly-Val-Val-(OMe)(Me). 

Phrase: "Thus,"

Phrase: "the dipeptide Boc-Gly-Val-OBn ("

Phrase: "made by BOP/HOBt/DIEA/DMF-mediated coupling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0044409:HOBt [Organic Chemical]
   744   C0060056:DMF [Therapeutic or Preventive Procedure]
   744   C0067365:DIEA [Organic Chemical]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C1948027:Coupling [Functional Concept]
   711   C1881534:Make [Functional Concept]

Phrase: "of Boc-Gly-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "with H-Val-OBn)"

Phrase: "was"

Phrase: "saponified"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "coupled with the Weinreb valine amide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0002482:Amide [Organic Chemical]
   753   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]

Phrase: "(H-Val-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(OMe)("

Phrase: "Me"

Phrase: ")"

Phrase: ","

Phrase: "Aldrich"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BOP/HOBt/DIEA/DMF to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0060056:DMF [Therapeutic or Preventive Procedure]

Phrase: "yield"

Phrase: "the Weinreb tripeptide Boc-Gly-Val-Val-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0078011:Val-Val [Amino Acid, Peptide, or Protein]

Phrase: "(OMe)("

Phrase: "Me"

Phrase: ")."
Processing 00000000.tx.46: The diisobutylaluminum hydride reduction of this product furnished, after silica gel purification, the inhibitor Boc-Gly-Val-Val-CHO in good overall yield. 

Phrase: "The diisobutylaluminum hydride reduction of this product furnished,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "after"

Phrase: "silica gel purification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243114:purification [Functional Concept]
   827   C1998793:Purification [Functional Concept]
   734   C2936385:Silica Gel [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "the inhibitor Boc-Gly-Val-Val-CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0018555:Chinese Hamster [Mammal]
   793   C0008120:chinese [Language]
   793   C0018557:Hamster [Mammal]
   793   C0029939:Ovary [Body Part, Organ, or Organ Component]
   793   C0152035:Chinese [Population Group]
   793   C0227898:ovary [Body Part, Organ, or Organ Component]
   793   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "in good overall yield."
Processing 00000000.tx.47: Mutant PS Constructs-- Each PS mutant was constructed by generating two polymerase chain reaction fragments from wild type (wt) PS1 cDNA template. 

Phrase: "Mutant PS Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "-"

Phrase: "-"

Phrase: "Each PS mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "constructed by generating two polymerase chain reaction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0205448:Two [Quantitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   714   C2827421:Construct [Classification]

Phrase: "fragments from wild type (wt) PS1 cDNA template."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332255:fragment [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0486805:Fragments [Body Substance]
   748   C0728990:TEMPLATE [Medical Device]
   748   C1418985:PS1 [Gene or Genome]
   748   C1514575:Template [Conceptual Entity]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705542:Template [Idea or Concept]
   748   C1708096:Fragment [Qualitative Concept]
   748   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.48: The 5'-segment was produced using a forward primer to generate an HindIII site at the 5'-end of PS1 and a specific reverse primer from the actual site of mutation, which also created a class IIa restriction site (BsmBI). 

Phrase: "The 5'-segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441635:Segment [Spatial Concept]
   789 E C0205122:Segmental [Spatial Concept]

Phrase: "was"

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a forward primer to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1953382:Forward primer [Cell]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "generate"

Phrase: "an HindIII site at the 5'-end of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a specific reverse primer from the actual site of mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   739   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which also"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "a class IIa restriction site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(BsmBI"

Phrase: ")."
Processing 00000000.tx.49: The BsmBI site is removed by the restriction enzyme leaving the final sequence unaltered except for the specific desired mutation. 

Phrase: "The BsmBI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "removed by the restriction enzyme"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   760   C0849355:Removed [Qualitative Concept]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "leaving"

Phrase: "the final sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "unaltered except for the specific desired mutation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709843:Unaltered [Qualitative Concept]
Processing 00000000.tx.50: A similar strategy was used to generate the 3'-end of the cDNA, terminating in a BamHI site. 

Phrase: "A similar strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the 3'-end of the cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "terminating in a BamHI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.51: Following the appropriate restriction digests, the pieces were assembled by triple ligation in the pAG3hyg vector (11). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the appropriate restriction digests,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0868946:Digests [Physiologic Function]

Phrase: "the pieces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2982836:Piece [Quantitative Concept]

Phrase: "were"

Phrase: "assembled by triple ligation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023690:Ligation [Therapeutic or Preventive Procedure]
   770   C0205174:Triple [Quantitative Concept]
   737   C1706853:Assemble [Activity]

Phrase: "in the pAG3hyg vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.52: All mutations were verified by sequencing (primer sequences are available on request). 

Phrase: "All mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "verified by sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   790   C1711411:Verified [Functional Concept]

Phrase: "(primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "available on request"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ")."
Processing 00000000.tx.53: In this manner we generated four PS1 aspartate mutants (D257A or E, D385A or E; D A/E), the PS ins254-6+ins386-8 (PS "out") mutant, which contains amino acid insertions of SVY at position 256and FIF at position 388(duplicating the amino- and carboxyl-terminally adjacent 3residues, respectively), and TM1-2, which contains a deletion from amino acids 81-154 (inclusive). 

Phrase: "In this manner"

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "four PS1 aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(D257A"

Phrase: "or"

Phrase: "E,"

Phrase: "D385A"

Phrase: "or"

Phrase: "E"

Phrase: "; D A/E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")"

Phrase: ","

Phrase: "the PS ins254-6+ins386-8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0616908:PS-8 [Antibiotic,Organic Chemical]
   853   C0072521:PS-6 [Organic Chemical,Pharmacologic Substance]
   804   C1418867:Ps [Gene or Genome]
   804   C1518860:PS [Geographic Area]
   804   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(PS ""out"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "amino acid insertions of SVY"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441587:insertions [Health Care Activity]
   726 E C0021107:Insertion [Therapeutic or Preventive Procedure]
   726 E C1512796:Insertion [Genetic Function]
   726 E C1883719:Insertion [Functional Concept]

Phrase: "at position 256and FIF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1851124:FIF [Disease or Syndrome]

Phrase: "at position 388"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "("

Phrase: "duplicating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205173:duplicating [Functional Concept]
   966 E C3539942:Duplicate [Intellectual Product]

Phrase: "the amino-"

Phrase: "and"

Phrase: "carboxyl-terminally adjacent 3residues,"

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "TM1-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a deletion from amino acids 81-154"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "(inclusive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332257:Inclusive [Functional Concept]

Phrase: ")."
Processing 00000000.tx.54: Generation of Pooled Stable Lines-- 70% confluent 6-well plates of either Chinese hamster ovary (CHO), human embryonic kidney 293(HEK), or human neuroglioma (H4) cells were transfected with 1g of plasmid DNA preincubated with 3l of FuGene 6transfection reagent (Roche Molecular Biochemicals) in serum-free OptiMEM (Life Technologies, Inc.) overnight. 

Phrase: "Generation of Pooled Stable Lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "--"

Phrase: "70% confluent 6-well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205170:Well [Qualitative Concept]
   812   C0205200:Confluent [Qualitative Concept]
   812   C3146287:Well [Manufactured Object]

Phrase: "plates of either Chinese hamster ovary (CHO),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0018555:Chinese Hamster [Mammal]
   753   C0005971:Plate [Medical Device]
   753   C0008120:chinese [Language]
   753   C0018557:Hamster [Mammal]
   753   C0029939:Ovary [Body Part, Organ, or Organ Component]
   753   C0152035:Chinese [Population Group]
   753   C0227898:ovary [Body Part, Organ, or Organ Component]
   753   C1139930:plate [Medical Device]
   753   C1278992:Ovary [Body Part, Organ, or Organ Component]
   753   C3537155:Plate [Manufactured Object]

Phrase: "human embryonic kidney 293"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0086418:Human [Human]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1514845:KIDNEY [Tissue]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(HEK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C0812263:HEK [Gene or Genome]
  1000   C1704817:HEK [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "human neuroglioma"

Phrase: "(H4"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 1g of plasmid DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "preincubated with 3l of FuGene 6transfection reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   748   C0916399:FuGene [Lipid]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "in serum-free OptiMEM"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.55: Media were then replaced with either Ham's F-12 (CHO cells), Dulbecco's modified Eagle's (HEK cells), or OptiMEM (H4 cells) media supplemented with 10% fetal bovine serum (Hyclone) and 800g/ml Hygromycin B (Calbiochem). 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "replaced with either Ham's F-12"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C0559956:Replaced [Functional Concept]
   753   C1299987:replaced [Functional Concept]
   753   C1553038:[f] [Quantitative Concept]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "(CHO cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "Dulbecco's modified Eagle's"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0325564:Eagle [Bird]
   827   C1551720:Eagle [Population Group]

Phrase: "(HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "OptiMEM"

Phrase: "(H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Hyclone"

Phrase: ")"

Phrase: "and"

Phrase: "800g/ml Hygromycin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020406:Hygromycin B [Carbohydrate,Pharmacologic Substance]
   812   C0063201:hygromycin [Organic Chemical]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.56: After 10-14 days, selection was reduced to 200g/ml. 

Phrase: "After 10-14 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1547061:10 days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "was"

Phrase: "reduced to 200g/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Reduced [Qualitative Concept]
   770   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.57: Expression levels were monitored periodically by immunoblotting throughout the course of the experiment, and have been maintained for multiple passages. 

Phrase: "Expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "periodically by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0332182:Periodically [Temporal Concept]

Phrase: "throughout the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "maintained for multiple passages."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439064:Multiple [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
   737   C0439799:Passage [Spatial Concept]
Processing 00000000.tx.58: Transient transfections were performed in an identical manner, albeit without hygromycin selection. 

Phrase: "Transient transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed in an identical manner,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "albeit without hygromycin selection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036576:selection [Genetic Function]
   770   C0063201:hygromycin [Organic Chemical]
Processing 00000000.tx.59: All cell lines were maintained at 37C under 5% CO2. 

Phrase: "All cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "maintained at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "under 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.60: A Analysis-- A was analyzed by sandwich enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation/mass spectrometry (IP/MS) as described previously (11). 

Phrase: "A Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "A"

Phrase: "was"

Phrase: "analyzed by sandwich enzyme-linked immunosorbent assay (ELISA)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0936012:Analyzed [Research Activity]
   748   C1510438:Assay [Laboratory Procedure]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "immunoprecipitation/mass spectrometry (IP/MS)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.61: Briefly, serum-free media samples were collected following overnight conditioning, complete protease inhibitor cocktail added (PIC; Roche Molecular Biochemicals), and total A concentration was measured by 3160/4G8 sandwich ELISA. 

Phrase: "Briefly,"

Phrase: "serum-free media samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C0444266:Serum sample [Body Substance]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
   756   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "overnight conditioning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009647:Conditioning [Mental Process]

Phrase: "complete protease inhibitor cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678420:Cocktail [Food]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "(PIC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "; Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured by 3160/4G8 sandwich ELISA."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   818   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   762   C2717977:Enzyme Assay [Laboratory Procedure]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   742   C0243073:assay [Qualitative Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]
Processing 00000000.tx.62: The amount of A was standardized (to correct for transfection efficiency) to sAPP levels measured in the same sample using an Ab207 competitive ELISA with plates coated with 60ng/well purified, recombinant sAPP (11). 

Phrase: "The amount of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "standardized"

Phrase: "("

Phrase: "to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: ")"

Phrase: "to sAPP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "measured in the same sample"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C2348149:Sample Measure [Quantitative Concept]
   760   C0370003:Sample [Substance]
   760   C0444706:Measured [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Ab207 competitive ELISA with plates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   762   C2717977:Enzyme Assay [Laboratory Procedure]
   745   C0441685:Plate assay [Laboratory Procedure]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]

Phrase: "coated with 60ng/well"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1522408:Coated [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "recombinant sAPP (11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514798:recombinant [Organism]

Phrase: ")."
Processing 00000000.tx.63: A40 and A42 were measured by BAN50/BA27 and BAN50/BC05 ELISA, respectively. 

Phrase: "A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "measured by BAN50/BA27"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "BAN50/BC05 ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   858   C2717977:Enzyme Assay [Laboratory Procedure]
   799   C0005507:Assay [Laboratory Procedure]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]
   766   C1517892:Link [Intellectual Product]
   766   C1704666:Link [Intellectual Product]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.64: All measurements were performed in duplicate. 

Phrase: "All measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.65: For mass spectrometry, conditioned serum-free media from APP-transfected CHO cells was immunoprecipitated with 4G8/protein-A/G-plus-agarose beads and subjected to matrix-assisted laser desorption/time-of-flight mass spectrometry analysis as described (26). 

Phrase: "For mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "conditioned serum-free media"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   923   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   902   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C0229671:Serum [Body Substance]
   812   C0332296:free [Functional Concept]
   812   C1254021:Media [Tissue]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "from APP-transfected CHO cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   847   C0018956:precursor cell [Cell]
   827   C0085080:Chinese Hamster Ovary Cell [Cell]
   812   C0018555:Chinese Hamster [Mammal]
   793   C0007634:Cells [Cell]
   793   C0008120:chinese [Language]
   793   C0018557:Hamster [Mammal]
   793   C0029939:Ovary [Body Part, Organ, or Organ Component]
   793   C0152035:Chinese [Population Group]
   793   C0227898:ovary [Body Part, Organ, or Organ Component]
   793   C1278992:Ovary [Body Part, Organ, or Organ Component]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "immunoprecipitated with 4G8/protein-A/G-plus-agarose beads"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0060916:protein g [Amino Acid, Peptide, or Protein]
   762   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036681:Agarose [Carbohydrate]
   742   C0332287:Plus [Qualitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0991566:Beads [Biomedical or Dental Material]
   708   C0301871:Immunoprecipitate [Immunologic Factor]
   708 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to matrix-assisted laser desorption/time-of-flight mass spectrometry analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   850   C1718396:Time of analysis [Temporal Concept]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.66: Western Blotting-- Cells were lysed in ice-cold 1% Triton X-100/TBS (pH 8.0)+PIC, and the insoluble material was separated by high speed centrifugation (20,000g). 

Phrase: "Western Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "in ice-cold 1% Triton X-100/TBS (pH 8.0"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   821   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   804   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0456963:Ice cold [Qualitative Concept]
   790   C0009264:Cold [Natural Phenomenon or Process]
   790   C0009443:Cold [Disease or Syndrome]
   790   C0020283:[pH] [Quantitative Concept]
   790   C0020746:Ice [Inorganic Chemical]
   790   C0234192:Cold [Physiologic Function]
   790   C0242759:Triton [Geographic Area]
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C0450407:ph+ [Finding]
   790   C0450408:ph++ [Finding]
   790   C0450409:ph+++ [Finding]
   790   C1532188:Tbsp [Quantitative Concept]

Phrase: ")"

Phrase: "+PIC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "and"

Phrase: "the insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "separated by high speed centrifugation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205250:High [Qualitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0678536:Speed [Quantitative Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(20,"

Phrase: "000g"

Phrase: ")."
Processing 00000000.tx.67: Lysates (10-15 g of total protein, by bicinchoninic acid assay) were separated on 10-20% Tris-Tricine gels, transferred to polyvinylidene difluoride membranes, blocked overnight with 5% non-fat dried milk/TBS (pH 7.4)/0.05% Tween 20,and immunoblotted. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "(10-15 g of total protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439267:g% [Quantitative Concept]

Phrase: "by bicinchoninic acid assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "were"

Phrase: "separated on 10-20% Tris-Tricine gels,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   774   C1630409:20/10 [Finding]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0814229:TRI [Intellectual Product]
   714 E C1382104:Gel [Substance]

Phrase: "transferred to polyvinylidene difluoride membranes,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "with 5% non-fat dried milk/TBS (pH 7.4"
Meta Candidates (Total=25; Excluded=5; Pruned=0; Remaining=20)
   817   C0991850:fat milk [Lipid,Pharmacologic Substance]
   817   C2678549:PH-4 [Gene or Genome]
   807   C0452721:Dried milk [Food]
   807   C1882074:pH 7 [Qualitative Concept]
   791   C0020283:[pH] [Quantitative Concept]
   791   C0026131:Milk [Body Substance]
   791   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   791   C0349374:Milk [Food]
   791   C0424612:FAT [Organism Attribute]
   791   C0439084:>5 [Quantitative Concept]
   791   C0444318:Milk [Substance]
   791   C0450407:ph+ [Finding]
   791   C0450408:ph++ [Finding]
   791   C0450409:ph+++ [Finding]
   791   C0728893:+5 [Quantitative Concept]
   791   C1512080:Dried [Qualitative Concept]
   791   C1518422:Non [Functional Concept]
   791   C1532188:Tbsp [Quantitative Concept]
   791   C2825079:Milk [Food]
   791   C2827485:Dried [Body Substance]
   758 E C0011682:Dry [Natural Phenomenon or Process]
   758 E C0205222:Dry [Qualitative Concept]
   735 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   735 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   720 E C0443260:Milky [Finding]

Phrase: ")"

Phrase: "/0.05% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.68: PS1 was visualized with rabbit anti-PS1 loop and/or anti-PS1-N antibodies (each at 1:1000 dilution) (27). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "visualized with rabbit anti-PS1 loop"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0034493:Rabbit [Mammal]
   753   C0234621:Visualized [Functional Concept]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "and/or"

Phrase: "anti-PS1-N antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   708   C0432633:Anti N [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "("

Phrase: "each at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "1000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.69: For APP, blots were probed with anti-CT20 antibody (1:500 dilution). 

Phrase: "For APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "blots"

Phrase: "were"

Phrase: "probed with anti-CT20 antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1842761:CT20 [Gene or Genome]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")."
Processing 00000000.tx.70: Metabolic Labeling-- Confluent 6-well plates of pooled stable HEK293 cells or HEKwt cells were labeled for 2h with 200Ci/well [35S]methionine/cysteine. 

Phrase: "Metabolic Labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "--"

Phrase: "Confluent 6-well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C0205200:Confluent [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "plates of pooled stable HEK293 cells"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   790   C2936239:HEK293 Cells [Cell]
   783   C1166718:cells plate [Cell Component]
   753   C0005971:Plate [Medical Device]
   753   C0007634:Cells [Cell]
   753   C0205360:Stable [Qualitative Concept]
   753   C1139930:plate [Medical Device]
   753   C1547311:Stable [Intellectual Product]
   753   C1709595:Pooled [Conceptual Entity]
   753   C2349200:Pooled [Functional Concept]
   753   C3282337:Cells [Cell]
   753   C3537155:Plate [Manufactured Object]
   719 E C0337051:Pool [Geographic Area]
   719 E C1269647:Cell [Cell]
   719 E C1509144:pool [Clinical Attribute]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "HEKwt cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled for 2h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1292425:2H [Temporal Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with 200Ci/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "[35S"

Phrase: "]methionine/cysteine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.71: For inducible -secretase experiments, cells were treated with 1M phorbol 12,13-dibutyrate (PDBu), and serum-free conditioned media were collected after 6h. 

Phrase: "For inducible -secretase experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 1M phorbol 12,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0031588:phorbol [Organic Chemical]
   760   C0070750:Phorbol [Organic Chemical]
   760   C0470296:1M [Quantitative Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "13-dibutyrate (PDBu),"

Phrase: "and"

Phrase: "serum-free conditioned media"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C1254021:Media [Tissue]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected after 6h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292428:6H [Temporal Concept]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
Processing 00000000.tx.72: Total sAPP was immunoprecipitated with Ab207/protein-G-agarose beads, separated on 10% Tris-Tricine gels, dried, and exposed to a low energy phosphor screen for 7days. 

Phrase: "Total sAPP"

Phrase: "was"

Phrase: "immunoprecipitated with Ab207/protein-G-agarose beads,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Agarose [Carbohydrate]
   748   C0439267:g% [Quantitative Concept]
   748   C0991566:Beads [Biomedical or Dental Material]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
   714 E C2346972:Bead [Spatial Concept]

Phrase: "separated on 10% Tris-Tricine gels,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077068:tricine [Organic Chemical]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C0814229:TRI [Intellectual Product]
   719 E C1382104:Gel [Substance]

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "exposed to a low energy phosphor screen"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0205251:low [Qualitative Concept]
   748   C0220908:screen [Health Care Activity]
   748   C0259980:phosphor [Chemical Viewed Functionally]
   748   C0424589:Energy [Finding]
   748   C0542479:Energy [Natural Phenomenon or Process]
   748   C1299352:Low [Qualitative Concept]
   748   C1305399:screen [Functional Concept]
   748   C1442080:Energy [Quantitative Concept]
   748   C1550472:low [Idea or Concept]
   748   C1705053:Screen [Medical Device]

Phrase: "for 7days."
Processing 00000000.tx.73: Data were analyzed using a Storm PhosphorImager (Molecular Dynamics) and ImageQuaNTTM software. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Storm PhosphorImager"

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "ImageQuaNTTM software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.74: For analysis of CTF, APP from Triton X-100-lysed cells was immunoprecipitated with rabbit anti-CT-20, separated on 10-20% Tris-Tricine gels, and analyzed as above. 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of CTF,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "APP from Triton X-100-lysed cells"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   762   C0018956:cells precursor [Cell]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "immunoprecipitated with rabbit anti-CT-20,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0034493:Rabbit [Mammal]
   753   C3540513:CT [Gene or Genome]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "separated on 10-20% Tris-Tricine gels,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   774   C1630409:20/10 [Finding]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0814229:TRI [Intellectual Product]
   714 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "analyzed as above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.75: Glycerol Density Centrifugation-- Digitonin lysates were prepared, and equal amounts (1.5mg) of protein from cells expressing TM1-2 mutant and wild type PS1 were combined. 

Phrase: "Glycerol Density Centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "--"

Phrase: "Digitonin lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "equal amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "(1.5mg"

Phrase: ")"

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "TM1-2 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "wild type PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "combined."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.76: The combined lysate was layered onto a 10-40% linear glycerol gradient, centrifuged, acetone-precipitated, and separated by SDS-polyacrylamide gel electrophoresis as described (28). 

Phrase: "The combined lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "layered onto a 10-40% linear glycerol gradient,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   744   C0205132:Linear [Spatial Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0439509:/40 [Temporal Concept]
   744   C0812409:Gradient [Quantitative Concept]
   744   C0934502:Layered [Body Part, Organ, or Organ Component]
   711 E C1522408:Layer [Qualitative Concept]
   711 E C1561599:Layer [Intellectual Product]

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "acetone-precipitated,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "separated by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.77: Immunoblots were probed with antibody NT1 to PS141-49 (29).  

Phrase: "Immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "were"

Phrase: "probed with antibody NT1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "to PS141-49"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.78: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -40 and -42 Secretase Activities Are Pharmacologically and Spatially Distinct-- To further establish the existence of pharmacologically distinct -secretase cleavage sites, we examined the effects of a substrate-based (40-site) aldehyde inhibitor (Boc-glycine-valine-valinal; GVV) on A production and APP CTF. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -40"
Meta Candidates (Total=23; Excluded=4; Pruned=0; Remaining=19)
   796   C1293116:Introduction procedure [Health Care Activity]
           Introduction
   790   C0000857:Abstract [Occupational Activity]
   790   C0025664:procedures [Intellectual Product]
   790   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   790   C0439509:/40 [Temporal Concept]
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C0600678:Abstract [Intellectual Product]
   790   C1517586:Experimental [Qualitative Concept]
   790   C1552863:Abstract [Idea or Concept]
   790   C1704458:Top [Spatial Concept]
   790   C1875307:INTRODUCTION [Manufactured Object]
   790   C2584313:Discussion [Social Behavior]
   790   C2700391:procedures [Activity]
   756   C1274040:Result [Functional Concept]
   756   C1514811:Reference [Idea or Concept]
   756   C1546471:Result [Idea or Concept]
   756   C1706462:Reference [Conceptual Entity]
   756 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   756   C2825142:Result [Finding]
   756 E C3274430:PROCEDURE [Health Care Activity]
   756 E C3538935:Procedure [Idea or Concept]
   756 E C3539779:Procedure [Intellectual Product]

Phrase: "and -"

Phrase: "42 Secretase Activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "Are"

Phrase: "Pharmacologically"

Phrase: "and"

Phrase: "Spatially Distinct"

Phrase: "--"

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the existence of pharmacologically distinct -secretase cleavage sites,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of a substrate-based"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(40-site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "aldehyde inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Boc-glycine-valine-valinal"

Phrase: "; GVV"

Phrase: ")"

Phrase: "on A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "APP CTF."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.79: When tested on transiently transfected 293T cells overexpressing APP695NL, GVV increased APP CTF in a dose-dependant fashion (data not shown) and selectively inhibited A cleavage at sites other than 42,as measured both by ELISA (Fig. 1A) and (IP/MS) (Fig. 1B). 

Phrase: "When"

Phrase: "tested on transiently transfected 293T cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C0392366:tested [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "APP695NL,"

Phrase: "GVV"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "APP CTF in a dose-dependant fashion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   738   C0332255:fragments [Functional Concept]
   738   C0486805:Fragments [Body Substance]
   737   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   704 E C1708096:Fragment [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "selectively"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A cleavage at sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "other than 42,"

Phrase: "as"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "both by ELISA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0238767:Both [Spatial Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1706086:Both [Qualitative Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and ("

Phrase: "IP/MS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: The selective inhibition of cleavages other than A42 by GVV is qualitatively similar to the effects on A production observed with pepstatin (11), other peptide aldehydes (23), and some difluoroketone compounds (21); 

Phrase: "The selective inhibition of cleavages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "other than A42"

Phrase: "by GVV"

Phrase: "is"

Phrase: "qualitatively similar to the effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "on A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "observed with pepstatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1441672:Observed [Functional Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "other peptide aldehydes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001992:Aldehydes [Organic Chemical]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "some difluoroketone compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "(21"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.81: however, GVV appears to be even more selective than those previously reported with doses that inhibit A40 by >90% while not inhibiting A42 production. 

Phrase: "however,"

Phrase: "GVV"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "even more selective than those previously"

Phrase: "reported with doses"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0178602:Doses [Quantitative Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C0869039:Dose [Quantitative Concept]
   756 E C1114758:Dose # [Clinical Attribute]
   756 E C1428722:DOS [Gene or Genome]
   756 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A40 by"

Phrase: ">90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "while"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "A42 production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.82: Significantly, we have recently observed selective inhibition of A40 production by GVV, pepstatin, and other peptide aldehyde inhibitors in an in vitro assay of -secretase activity,2 indicating that the selectivity is not simply an issue of differential cell penetrance of the inhibitor. 

Phrase: "Significantly,"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "selective inhibition of A40 production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by GVV,"

Phrase: "pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "other peptide aldehyde inhibitors in an in vitro assay of -secretase activity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0243077:inhibitors [Chemical Viewed Functionally]
   703 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "indicating"

Phrase: "that"

Phrase: "the selectivity"

Phrase: "is"

Phrase: "not simply"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "an issue of differential cell penetrance of the inhibitor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0033213:Issue [Finding]
   742   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.83: Thus, the elevations in A42 production seen at low concentrations are best explained by an increased availability of APP CTF to a distinct -42 activity that is less sensitive to inhibition by GVV. 

Phrase: "Thus,"

Phrase: "the elevations in A42 production"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0702240:elevations [Spatial Concept]
   726 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "seen at low concentrations"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0086045:Concentrations [Mental Process]
   770   C0205251:low [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0042789:see [Organism Function]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1947903:See [Activity]

Phrase: "are"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "explained by an increased availability of APP CTF"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   770   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   766 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0470187:Availability of [Functional Concept]
           Availability
   753   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205088:Terminal [Temporal Concept]
   736   C0205217:Increased [Quantitative Concept]
   736   C0332255:fragments [Functional Concept]
   736   C0442805:Increased [Functional Concept]
   736   C0486805:Fragments [Body Substance]
   736   C0596260:Carboxyl [Organic Chemical]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1709634:Precursor [Idea or Concept]
   734   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   703 E C1708096:Fragment [Qualitative Concept]

Phrase: "to a distinct -42 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "less sensitive to inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "by GVV."
Processing 00000000.tx.84: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.85: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.86: GVV-sensitive and GVV-insensitive -secretase activities. 

Phrase: "GVV-sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "GVV-insensitive -secretase activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.87: A, inhibitor profile for GVV. 

Phrase: "A,"

Phrase: "inhibitor profile for GVV."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1979963:Profile [Laboratory Procedure]
   770   C2003903:Profile [Functional Concept]
Processing 00000000.tx.88: CHO cells stably expressing human wt APP were treated overnight with the indicated concentrations of GVV, and serum-free-conditioned media samples were collected with protease inhibitors. 

Phrase: "CHO cells stably"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   904   C0085080:Chinese Hamster Ovary Cell [Cell]
   840   C0018555:Chinese Hamster [Mammal]
   804   C0007634:Cells [Cell]
   804   C0008120:chinese [Language]
   804   C0018557:Hamster [Mammal]
   804   C0029939:Ovary [Body Part, Organ, or Organ Component]
   804   C0152035:Chinese [Population Group]
   804   C0227898:ovary [Body Part, Organ, or Organ Component]
   804   C1278992:Ovary [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human wt APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   799   C1709634:Precursor [Idea or Concept]
   709   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "overnight with the indicated concentrations of GVV,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0086045:Concentrations [Mental Process]
   748   C0439583:Overnight [Temporal Concept]
   748   C1444656:Indicated [Finding]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "serum-free-conditioned media samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0444266:Serum sample [Body Substance]
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]
   722   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "collected with protease inhibitors."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1947941:Protease [Enzyme]
   737 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.89: Total A production as assayed by 3160/4G8 ELISA is inhibited in a dose-dependent manner, whereas A42 is slightly increased at lower concentrations and relatively unaffected at concentrations that nearly eliminate production of shorter A species. 

Phrase: "Total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "assayed by 3160/4G8 ELISA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   750   C2717977:Enzyme Assay [Laboratory Procedure]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "is"

Phrase: "inhibited in a dose-dependent manner,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "whereas"

Phrase: "A42"

Phrase: "is"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increased at lower concentrations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0086045:Concentrations [Mental Process]
   770   C0205217:Increased [Quantitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "relatively unaffected at concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "that nearly"

Phrase: "eliminate"

Phrase: "production of shorter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "A species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.90: No obvious toxicity was apparent at these concentrations. 

Phrase: "No obvious toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "apparent at these concentrations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.91: Total sAPP secretion was unaffected by GVV (data not shown). 

Phrase: "Total sAPP secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "unaffected by GVV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: Results shown are averaged from three experiments, and all ELISA measurements were performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "averaged from three experiments,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205449:Three [Quantitative Concept]
   770   C0681814:Experiments [Research Activity]
   737   C1510992:Average [Quantitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "all ELISA measurements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0014440:Enzyme measurement [Laboratory Procedure]
   804   C0242485:measurements [Functional Concept]
   771   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   708   C2717977:Enzyme Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.93: B, schematic of -secretase cleavage site utilization and GVV sensitivity of APP TMD mutants. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "schematic of -secretase cleavage site utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "GVV sensitivity of APP TMD mutants."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0036667:Sensitivity [Quantitative Concept]
   742   C0312418:Sensitivity [Mental Process]
   742   C0427965:Sensitivity [Finding]
   742   C1511883:Sensitivity [Quantitative Concept]
   742   C1522640:Sensitivity [Qualitative Concept]
   742   C2346484:SENSITIVITY [Phenomenon or Process]
   742   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.94: The amino acid sequence of the APP TMD is shown. 

Phrase: "The amino acid sequence of the APP TMD"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   813   C0920679:aminoacid sequence of protein [Amino Acid Sequence]
   775   C0002518:Amino Acid Sequence [Amino Acid Sequence]
           Protein Sequence
   772   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C2917660:Amino Acid [Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0202406:Acid [Laboratory Procedure]
   738   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.95: Mutations (including the insertion) are shown in blue; 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown in blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1260957:Blue [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.96: the position of the GAII deletion is indicated with the arrowhead. 

Phrase: "the position of the GAII deletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "is"

Phrase: "indicated with the arrowhead."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0453107:Arrowhead [Food]
   770   C1080898:Arrowhead [Plant]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.97: Mass spectrometric analyses of A peptide secreted by the TMD mutants are schematically depicted. 

Phrase: "Mass spectrometric analyses of A peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "secreted by the TMD mutants"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1519623:Transmembrane Domain [Amino Acid Sequence]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1167322:transmembrane [Cell Component]
   753   C1327616:Secreted [Cell Function]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2752508:transmembrane [Cell Component]
   753   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "schematically"

Phrase: "depicted."
Processing 00000000.tx.98: The carboxyl terminus of the A peptides detected in each mutant are indicated by arrows above the cleavage sites (all A species detected by the methods used in this study begin at A1), whereas the height of the arrows indicates relative peptide amount. 

Phrase: "The carboxyl terminus of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596260:Carboxyl [Organic Chemical]

Phrase: "A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "detected in each mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "indicated by arrows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]

Phrase: "above the cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "all A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "detected by the methods"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0442726:Detected [Finding]
   770   C0449851:Methods [Functional Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "begin at A1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439659:Begin [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the height of the arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0489786:Height [Organism Attribute]

Phrase: "indicates"

Phrase: "relative peptide amount."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.99: Black arrows indicate a cleavage inhibited >50% by 250M GVV, red arrows indicate cleavages increased by GVV, and the orange arrow indicates a cleavage inhibited <50%. 

Phrase: "Black arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "a cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: ">50% by 250M GVV,"

Phrase: "red arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0010813:cleavage [Cell Function]
   966   C0596311:Cleavage [Phenomenon or Process]
   966   C1330957:cleavage [Cell Function]

Phrase: "increased by GVV,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "the orange arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "a cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "<50%."
Processing 00000000.tx.100: These effects are similar to those obtained with pepstatin in these same APP TMD mutants (11). 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "obtained with pepstatin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in these same APP TMD mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.101: Subsequent analysis of the effects of GVV treatment on -secretase cleavage in APP TMD mutants by ELISA (data not shown) and IP/MS (Fig. 1B) indicates that these mutants possess a variety of GVV-sensitive and -insensitive sites, further indicating that multiple proteolytic activities are involved in -secretase cleavage (11). 

Phrase: "Subsequent analysis of the effects of GVV treatment on -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "in APP TMD mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "by ELISA"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "IP/MS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "indicates"

Phrase: "that"

Phrase: "these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a variety of GVV-sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "and -"

Phrase: "insensitive sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "indicating"

Phrase: "that multiple proteolytic activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441655:Activities [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1947941:proteolytic [Enzyme]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.102: Interestingly, these data also revealed that those GVV-sensitive sites were closer to the luminal side of the APP TMD, whereas those GVV-insensitive sites were more distal. 

Phrase: "Interestingly,"

Phrase: "these data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "those GVV-sensitive sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "closer to the luminal side of the APP TMD,"

Phrase: "whereas"

Phrase: "those GVV-insensitive sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "more distal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:Distal [Spatial Concept]
Processing 00000000.tx.103: Thus, it appears that we can monitor at least two -secretase activities, a "-40 activity," which cleaves residues more proximal to the luminal side and a -42 activity, which cleaves residues more distal to the luminal side. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "can"

Phrase: "monitor at least two -secretase activities,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0030695:monitor [Health Care Activity]
   753   C0150369:monitor [Health Care Activity]
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0181904:Monitor [Medical Device]
   753   C0205448:Two [Quantitative Concept]
   753   C0441655:Activities [Activity]
   753   C0596972:Monitor [Medical Device]
   753   C1521743:Monitor [Professional or Occupational Group]
   753   C1704646:Monitor [Manufactured Object]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "a ""-40 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: """"

Phrase: "which"

Phrase: "cleaves"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "more proximal to the luminal side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205107:Proximal [Spatial Concept]

Phrase: "and"

Phrase: "a -42 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "cleaves"

Phrase: "residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "more distal to the luminal side."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205108:Distal [Spatial Concept]
Processing 00000000.tx.104: PS1 Mutants That Inhibit -Secretase Cleavage-- In addition to the aspartate mutants reported by Wolfe et al., we have identified two additional PS1 mutants that inhibit -secretase (Fig. 2). 

Phrase: "PS1 Mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "That"

Phrase: "Inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Secretase Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "-"

Phrase: "-"

Phrase: "In addition to the aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "reported by Wolfe et al.,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two additional PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: The first mutant, PS1 ins254-6+ins386-8 (PS1 out), was generated to assess whether location of the aspartates relative to the membrane was an important functional element. 

Phrase: "The first mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "PS1 ins254-6+ins386-8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1418985:PS1 [Gene or Genome]
   804   C2986918:PS1 [Gene or Genome]

Phrase: "(PS1 out"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "location of the aspartates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450429:Location [Spatial Concept]
   770   C1515974:Location [Body Location or Region]

Phrase: "relative to the membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "an important functional element."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.106: In this mutant, the aspartates are not mutated, but their positions shifted by two 3-amino acid insertions within the transmembrane domain, potentially moving both Asp-257 and Asp-385 toward the cytoplasm and out of phase with the potential catalytic site. 

Phrase: "In this mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "the aspartates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "but"

Phrase: "their positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "shifted by two 3-amino acid insertions"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0205448:Two [Quantitative Concept]
   748   C0333051:shifted [Functional Concept]
   748   C0441587:insertions [Health Care Activity]
   714 E C0021107:Insertion [Therapeutic or Preventive Procedure]
   714 E C1512796:Insertion [Genetic Function]
   714 E C1883719:Insertion [Functional Concept]
   714 E C2347509:Shift [Phenomenon or Process]

Phrase: "within the transmembrane domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: "potentially moving"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0560560:Moving [Organism Function]
   827 E C0578671:move [Finding]
   827 E C1269909:move [Functional Concept]
   827 E C1299988:move [Functional Concept]
   827 E C2699029:Move [Activity]

Phrase: "both Asp-257"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "and"

Phrase: "Asp-385 toward the cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010834:Cytoplasm [Cell Component]
   760   C0206293:Asp [Reptile]
   760   C3541260:ASP [Gene or Genome]

Phrase: "and"

Phrase: "out of phase with the potential catalytic site."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2945843:Site of [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0439787:Out [Spatial Concept]
   744   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.107: In the second mutant, TM1-2, the first two transmembrane domains of PS1 are deleted, theoretically preserving the topology of the remaining protein. 

Phrase: "In the second mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "TM1-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "the first two transmembrane domains of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C1167322:transmembrane [Cell Component]
   748   C2752508:transmembrane [Cell Component]
   745   C1519623:Transmembrane Domain [Amino Acid Sequence]
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: ","

Phrase: "theoretically"

Phrase: "preserving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0728887:Preserving [Functional Concept]

Phrase: "the topology of the remaining protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002812:Topology [Biomedical Occupation or Discipline]
Processing 00000000.tx.108: The inhibitory effect of this mutant on -secretase was identified during a screen for PS1 deletion mutants that altered A production. 

Phrase: "The inhibitory effect of this mutant on -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "identified during a screen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205396:Identified [Qualitative Concept]
   770   C0220908:screen [Health Care Activity]
   770   C1305399:screen [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1705053:Screen [Medical Device]

Phrase: "for PS1 deletion mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.109: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.110: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.111: PS1 mutants. 

Phrase: "PS1 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.112: Three different strategies were utilized to generate dominant negative PS1 mutants. 

Phrase: "Three different strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "were"

Phrase: "utilized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "dominant negative PS1 mutants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   906   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   812   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.113: First, deletion of the first two putative transmembrane domains (A: TM1-2, made by deleting amino acids 81through 154; 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "deletion of the first two putative transmembrane domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "(A"

Phrase: ":"

Phrase: "TM1-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "made by deleting amino acids 81through 154"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]
   714   C1880274:Delete [Activity]
   714   C1881534:Make [Functional Concept]

Phrase: ";"
Processing 00000000.tx.114: shaded region). 

Phrase: "shaded region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.115: Second, shifting the position of the two aspartates by duplicating the 3amino acids amino-terminal to Asp-257 (SVY) and the 3amino acids carboxyl-terminal to Asp-385 (FIF) (B: ins254-6+ins386-8, PS out). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "shifting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifting [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "the position of the two aspartates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "by duplicating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205173:duplicating [Functional Concept]
   966 E C3539942:Duplicate [Intellectual Product]

Phrase: "the 3amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "amino-terminal to Asp-257"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]

Phrase: "(SVY"

Phrase: ")"

Phrase: "and"

Phrase: "the 3amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "carboxyl-terminal to Asp-385"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205088:Terminal [Temporal Concept]
   760   C0596260:Carboxyl [Organic Chemical]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]

Phrase: "(FIF) (B"

Phrase: ":"

Phrase: "ins254-6+ins386-8,"

Phrase: "PS out"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.116: This mutation caused a shift of the position of the aspartate residues within the membrane, potentially moving the catalytic site out of position. 

Phrase: "This mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a shift of the position of the aspartate residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0333051:Shift [Functional Concept]
   742   C2347509:Shift [Phenomenon or Process]

Phrase: "within the membrane,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "potentially"

Phrase: "moving"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0560560:Moving [Organism Function]
   966 E C0578671:move [Finding]
   966 E C1269909:move [Functional Concept]
   966 E C1299988:move [Functional Concept]
   966 E C2699029:Move [Activity]

Phrase: "the catalytic site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0205681:Catalytic Site [Functional Concept]
  1000   C0600499:catalytic site [Amino Acid Sequence]
   861   C0007382:Catalytic [Natural Phenomenon or Process]
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "out of position."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0439787:Out [Spatial Concept]
   827   C0733755:Position [Spatial Concept]
   827   C0849355:Out [Qualitative Concept]
   755 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.117: Finally, point mutations at the actual aspartate residues (D257A or E, D385A or E; C). 

Phrase: "Finally,"

Phrase: "point mutations at the actual aspartate residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   748   C0026882:Mutations [Genetic Function]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(D257A"

Phrase: "or"

Phrase: "E,"

Phrase: "D385A"

Phrase: "or"

Phrase: "E"

Phrase: "; C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.118: Scissors, site of constitutive PS1 endoproteolysis. 

Phrase: "Scissors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175735:Scissors [Medical Device]

Phrase: "site of constitutive PS1 endoproteolysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.119: We examined the effects of PS1 DA/E, TM1-2, and PS out mutants on the -secretase cleavages in three different cell lines: H4, HEK, and CHO. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of PS1 DA/E,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "TM1-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "PS out mutants on the -secretase cleavages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in three different cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "H4,"

Phrase: "HEK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C0812263:HEK [Gene or Genome]
  1000   C1704817:HEK [Gene or Genome]

Phrase: "and"

Phrase: "CHO."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.120: In each of these, we established pooled stable lines expressing wild type PS1 or the PS1 mutants, and then assessed APP processing and A production after transient transfection with various APP expression constructs. 

Phrase: "In each"

Phrase: "of these,"

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "pooled stable lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild type PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "the PS1 mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "then assessed APP processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0033666:protein processing [Molecular Function]
   799   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A production after transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "with various APP expression constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2827421:Construct [Classification]
Processing 00000000.tx.121: To validate this system of transient transfection of APP into pooled stable PS1 lines, we performed extensive experiments on pooled stable lines expressing the FAD-linked PS1 mutants M139V and E280G. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "this system of transient transfection of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0449913:System [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]

Phrase: "into pooled stable PS1 lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "extensive experiments on pooled stable lines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "expressing"

Phrase: "the FAD-linked PS1 mutants M139V"

Phrase: "and"

Phrase: "E280G."
Processing 00000000.tx.122: An example of this validation for H4 cells is shown in Fig. 

Phrase: "An example of this validation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707959:Example [Conceptual Entity]

Phrase: "for H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.124: In these experiments, both M139V and E280G are overexpressed (Fig. 3A) and increase A42 production without significantly altering total A production (Fig. 3B). 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "both M139V"

Phrase: "and"

Phrase: "E280G"

Phrase: "are"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "and"

Phrase: "increase A42 production without significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.125: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.126: 3 also shows the results obtained for PS1 mutants that inhibit -secretase activity in H4 cells. 

Phrase: "3 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained for PS1 mutants"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   770   C1301820:Obtained [Functional Concept]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]
   737 E C1706701:Obtain [Activity]

Phrase: "that"

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase activity in H4 cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.127: In lines expressing the TM1-2 mutant, limited endoproteolysis of the smaller holoprotein (Fig. 3A) is indicated by the presence of a truncated amino-terminal fragment migrating at ~23 kDa. 

Phrase: "In lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "the TM1-2 mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "limited endoproteolysis of the smaller holoprotein"

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "is"

Phrase: "indicated by the presence of a truncated amino-terminal fragment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1444656:Indicated [Finding]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "migrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrating [Functional Concept]

Phrase: "at ~23 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.128: The use of pooled stable lines prevents us from precisely determining both the extent of cleavage and replacement of endogenous PS1. 

Phrase: "The use of pooled stable lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "us from precisely determining"

Phrase: "both the extent of cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "and"

Phrase: "replacement of endogenous PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035139:Replacement [Therapeutic or Preventive Procedure]
   770   C0559956:Replacement [Functional Concept]
   770   C1555302:Replacement [Idea or Concept]
Processing 00000000.tx.129: However, it is clear that overexpressed PS1 to some extent replaces endogenous PS1 (as indicated by decreased levels of endogenous PS1 NTF in the case of TM1-2), and aspartate mutants are cleaved less efficiently (D257E shown). 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that overexpressed PS1 to some extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418985:PS1 [Gene or Genome]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "replaces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550539:replaces [Idea or Concept]
  1000   C1553396:replaces [Idea or Concept]
  1000   C1554078:Replace [Idea or Concept]

Phrase: "endogenous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "("

Phrase: "as"

Phrase: "indicated by decreased levels of endogenous PS1 NTF"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   744   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1418985:PS1 [Gene or Genome]
   744   C1444656:Indicated [Finding]
   744   C2986918:PS1 [Gene or Genome]
   711 E C0456079:Level [Classification]
   711 E C0547047:Decrease [Quantitative Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "less efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "(D257E"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.130: This was confirmed by blotting with a human-specific PS1 antibody (Chemicon; not shown). 

Phrase: "This"

Phrase: "was"

Phrase: "confirmed by blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "with a human-specific PS1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Chemicon"

Phrase: ";"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: Significantly, following transient transfection with APP695NL, A production (total, A40 and A42) is greatly curtailed in these cells (Fig. 3B), and both the TM1-2 and PS1 out mutants (not shown) were at least as effective at inhibiting A production as were the aspartate mutations. 

Phrase: "Significantly,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transient transfection with APP695NL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A40"

Phrase: "and"

Phrase: "A42"

Phrase: ")"

Phrase: "is"

Phrase: "greatly"

Phrase: "curtailed in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "both the TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "PS1 out mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "were at least"

Phrase: "as effective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280519:effective [Qualitative Concept]
  1000   C1704419:Effective [Qualitative Concept]

Phrase: "at inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "were"

Phrase: "the aspartate mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.132: View larger version (54K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.134: Overexpression of PS1 mutants in H4 cells. 

Phrase: "Overexpression of PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in H4 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: A, lysates from H4 human neuroglioma cells (10g of total protein) were separated, transferred, and probed with a combination of anti-PS1-loop/anti-PS1-N. 

Phrase: "A,"

Phrase: "lysates from H4 human neuroglioma cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(10g of total protein"

Phrase: ")"

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: ","

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: ","

Phrase: "and"

Phrase: "probed with a combination"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "of anti-PS1-loop/anti-PS1-N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   895   C0432633:Anti N [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.136: As expected, PS1 holoprotein from TM1-2 is noticeably smaller than wild type PS1. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "PS1 holoprotein from TM1-2"

Phrase: "is"

Phrase: "noticeably smaller than wild type PS1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0547044:Smaller [Qualitative Concept]
   753   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.137: Replacement of endogenous PS1 is not complete in this cell line. 

Phrase: "Replacement of endogenous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035139:Replacement [Therapeutic or Preventive Procedure]
   770   C0559956:Replacement [Functional Concept]
   770   C1555302:Replacement [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "complete in this cell line."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007600:Cell Line [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:Line [Spatial Concept]
   760   C0205197:Complete [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.138: Also, TM1-2 is cleaved in H4 cells (smaller ~23 kDa TM1-2 derived NTF marked with an asterisk), whereas D257E is not cleaved efficiently. 

Phrase: "Also,"

Phrase: "TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "cleaved in H4 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   802   C0333853:Cleaved cell [Cell]
           Cleaved
   770   C0007634:Cells [Cell]
   770   C0205242:Cleaved [Spatial Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(smaller ~23 kDa TM1-2 derived NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "marked with an asterisk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   770   C2945706:asterisk [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "D257E"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "efficiently."
Processing 00000000.tx.139: B, ELISA analysis of secreted A from H4 cells transfected with APP. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "ELISA analysis of secreted A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "from H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.140: The reduction in A for total, A40, and A42 is equivalent for both D257E and TM1-2 (t test versus PS1wt: *=p<0.05). 

Phrase: "The reduction in A for total,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "A40,"

Phrase: "and"

Phrase: "A42"

Phrase: "is"

Phrase: "equivalent for both D257E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205163:Equivalent [Qualitative Concept]
   770   C0439185:equivalent [Quantitative Concept]

Phrase: "and"

Phrase: "TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "(t test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0871472:t-Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "versus"

Phrase: "PS1wt"

Phrase: ":"

Phrase: "*"

Phrase: "=p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.141: Two PS1 FAD mutants, E280G and M139V, are shown as positive controls for the pooled stable approach and ELISA measurement of A42. 

Phrase: "Two PS1 FAD mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "E280G"

Phrase: "and"

Phrase: "M139V,"

Phrase: "are"

Phrase: "shown as positive controls"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C1883676:Positive Control [Conceptual Entity]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "for the pooled stable approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "and"

Phrase: "ELISA measurement of A42."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0014440:Enzyme measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.142: To further investigate the effect of these PS1 mutants on -40 and -42 activities, pooled stable CHO and HEK cells overexpressing either PS1wt or one of the mutant constructs (Fig. 4) were transiently transfected with either APP695NL or the APP TMD mutants I637P, T639K, ins625-628, or del625-628. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of these PS1 mutants on -40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and -"

Phrase: "42 activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "stable CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0018555:Chinese Hamster [Mammal]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "either PS1wt"

Phrase: "or"

Phrase: "one of the mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with either APP695NL"

Phrase: "or"

Phrase: "the APP TMD mutants I637P,"

Phrase: "T639K,"

Phrase: "ins625-628,"

Phrase: "or"

Phrase: "del625-628."
Processing 00000000.tx.143: PS1 expression, total A, sAPP, and APP CTF were analyzed in these transfected cells. 

Phrase: "PS1 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "total A,"

Phrase: "sAPP,"

Phrase: "and"

Phrase: "APP CTF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed in these transfected cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C2963401:Cells analyzed [Finding]
   760   C0007634:Cells [Cell]
   760   C0936012:Analyzed [Research Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.144: As in H4 cells, overexpression of these PS1 mutants resulted in varying degrees of replacement of endogenous PS1 and inefficient endoproteolysis of the PS1 holoprotein. 

Phrase: "As in H4 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpression of these PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "resulted in varying degrees of replacement of endogenous PS1"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   742   C0035139:Replacement [Therapeutic or Preventive Procedure]
   742   C0205227:Endogenous [Functional Concept]
   742   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0449286:degrees [Quantitative Concept]
   742   C0542560:degrees [Intellectual Product]
   742   C0559956:Replacement [Functional Concept]
   742   C1418985:PS1 [Gene or Genome]
   742   C1555302:Replacement [Idea or Concept]
   742   C2986918:PS1 [Gene or Genome]
   708 E C0441889:Degree [Qualitative Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708 E C1561545:degree [Quantitative Concept]
   708 E C2348088:Degree [Quantitative Concept]
   708   C2825142:Result [Finding]

Phrase: "and"

Phrase: "inefficient endoproteolysis of the PS1 holoprotein."
Processing 00000000.tx.145: APP CTF accumulated both at steady state (Fig. 5A) and during a 2-h chase period after metabolic labeling, whereas no effect was observed on constitutive sAPP secretion or turnover of APP holoproteins (data not shown). 

Phrase: "APP CTF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "accumulated"

Phrase: "both at steady state"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0678587:steady state [Natural Phenomenon or Process]
   770   C0205361:Steady [Qualitative Concept]
   770   C0238767:Both [Spatial Concept]
   770   C1301808:State [Geographic Area]
   770   C1442792:State [Functional Concept]
   770   C1706086:Both [Qualitative Concept]
   770   C3148680:State [Geographic Area]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "and during a 2-h chase period"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0011744:h 2 [Element, Ion, or Isotope]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439531:/period [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1948053:Period [Temporal Concept]

Phrase: "after metabolic labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "whereas"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed on constitutive sAPP secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1441672:Observed [Functional Concept]

Phrase: "or"

Phrase: "turnover of APP holoproteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597297:Protein Turnover [Molecular Function]
   753   C0031227:turnover [Quantitative Concept]
   753   C0243127:turnover [Functional Concept]
   753   C0443331:Turnover [Health Care Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: A production from the APP695NL and APP TMD mutants was reduced dramatically when these constructs were expressed in CHO or HEK cells coexpressing these PS1 mutants (Fig. 5B), and IP/MS analyses indicated that all -secretase cleavages were inhibited equally irrespective of inhibitor sensitivity (Fig. 5C). 

Phrase: "A production from the APP695NL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "APP TMD mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "dramatically"

Phrase: "when"

Phrase: "these constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "expressed in CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0018555:Chinese Hamster [Mammal]
   760   C0008120:chinese [Language]
   760   C0018557:Hamster [Mammal]
   760   C0029939:Ovary [Body Part, Organ, or Organ Component]
   760   C0152035:Chinese [Population Group]
   760   C0227898:ovary [Body Part, Organ, or Organ Component]
   760   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "these PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig. 5B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IP/MS analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "all -secretase cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "were"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "equally irrespective of inhibitor sensitivity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C1999216:Inhibitor [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.147: These data indicate that these PS1 mutations regulate production of A produced by both the pepstatin/GVV-sensitive and pepstatin/GVV-insensitive -secretases. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "these PS1 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "regulate"

Phrase: "production of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "produced by both"

Phrase: "the pepstatin/GVV-sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332324:Sensitive [Functional Concept]
   827   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "pepstatin/GVV-insensitive -secretases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.148: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.149: 4.  

Phrase: "4."
Processing 00000000.tx.150: Overexpression of PS1 mutants in CHO and HEK cells. 

Phrase: "Overexpression of PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.151: Western blot analysis of PS1 in CHO- and HEK293-pooled stable cell lines used in this study (anti-PS1-N antibody). 

Phrase: "Western blot analysis of PS1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "in CHO-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK293-pooled stable cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C2936239:HEK293 Cell [Cell]
   867   C0598091:stable cell line [Cell]
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(anti-PS1-N antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   708   C0432633:Anti N [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.152: Overexpression of PS1 holoprotein is clearly visible as an increase in full-length PS1 band intensity. 

Phrase: "Overexpression of PS1 holoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "clearly visible as an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "in full-length PS1 band intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.153: Although the TM1-2 is not endoproteolyzed efficiently, the presence of the 23-kDa TM1-2-derived NTF (asterisk) indicates that it is cleaved to some degree. 

Phrase: "Although"

Phrase: "the TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "not endoproteolyzed efficiently,"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the 23-kDa TM1-2-derived NTF (asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C2945706:asterisk [Conceptual Entity]

Phrase: ")"

Phrase: "indicates"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "cleaved to some degree."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.154: View larger version (37K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.155: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.156: Effects of PS1 mutants on A production. 

Phrase: "Effects of PS1 mutants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.157: A, steady-state accumulation of APP CTF generated by -secretase (C99) and -secretase cleavage (C83) in PS1 aspartate mutants (blotted with CT-20). 

Phrase: "A,"

Phrase: "steady-state accumulation of APP CTF"

Phrase: "generated by -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C3146294:Generated [Activity]

Phrase: "(C99"

Phrase: ")"

Phrase: "and -"

Phrase: "secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "(C83"

Phrase: ")"

Phrase: "in PS1 aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "blotted with CT-20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.158: B, ELISA analysis of total A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "ELISA analysis of total A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.159: Pooled stable CHO and HEK lines stably expressing PS1wt, PS1 aspartate mutants, PS out, and TM1-2 were transiently transfected with the indicated APP TMD mutant or APP695NL control, and the total A and the sAPP were assayed by ELISA as described under "Experimental Procedures." 

Phrase: "Pooled stable CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0018555:Chinese Hamster [Mammal]
   804   C0008120:chinese [Language]
   804   C0018557:Hamster [Mammal]
   804   C0029939:Ovary [Body Part, Organ, or Organ Component]
   804   C0152035:Chinese [Population Group]
   804   C0227898:ovary [Body Part, Organ, or Organ Component]
   804   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK lines stably"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "PS1wt,"

Phrase: "PS1 aspartate mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "PS out,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated APP TMD mutant"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   782   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   775 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1519623:Transmembrane Domain [Amino Acid Sequence]
   757   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   757   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   757   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1167322:transmembrane [Cell Component]
   739   C1444656:Indicated [Finding]
   739   C1709634:Precursor [Idea or Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C2752508:transmembrane [Cell Component]
   739   C3541951:Domain [Intellectual Product]

Phrase: "or"

Phrase: "APP695NL control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the total A"

Phrase: "and"

Phrase: "the sAPP"

Phrase: "were"

Phrase: "assayed by ELISA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   767   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.160: The amount of secreted A relative to the corresponding PS1wt control was markedly reduced in every case (averaged from three independent experiments; error bars indicate S.D.). 

Phrase: "The amount of secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "A relative to the corresponding PS1wt control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced in every case"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392756:Reduced [Qualitative Concept]
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "averaged from three independent experiments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   726   C1510992:Average [Quantitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726   C2825518:AVERAGE [Quantitative Concept]

Phrase: "; error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.161: C, IP/MS analysis of A produced from APP TMD mutants in PS1 aspartate mutant cells. 

Phrase: "C,"

Phrase: "IP/MS analysis of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "produced from APP TMD mutants"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   800   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1519623:Transmembrane Domain [Amino Acid Sequence]
   767   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   750   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596988:mutants [Cell or Molecular Dysfunction]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1167322:transmembrane [Cell Component]
   744   C1709634:Precursor [Idea or Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C2752508:transmembrane [Cell Component]
   744   C3541951:Domain [Intellectual Product]

Phrase: "in PS1 aspartate mutant cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: No differences were seen among the MS profiles from the different PS1 mutant lines. 

Phrase: "No differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "seen among the MS profiles"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205397:Seen [Qualitative Concept]
   760   C2349943:Ms. [Conceptual Entity]
   760   C3539704:MS [Gene or Genome]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "from the different PS1 mutant lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.163: Schematic data from APP695NL and I637P are shown. 

Phrase: "Schematic data from APP695NL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "I637P"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.164: The MS profile of A peptides is essentially identical in both APP695NL and I637P for both PS1wt and PS1 mutant-expressing lines, indicating that the quantitative reduction of A by the PS1 aspartate mutants alters both pepstatin/GVV-sensitive and pepstatin/GVV-insensitive -secretase cleavages equivalently. 

Phrase: "The MS profile of A peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "essentially identical in both APP695NL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "I637P for both PS1wt"

Phrase: "and"

Phrase: "PS1 mutant-expressing lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the quantitative reduction of A by the PS1 aspartate mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "both pepstatin/GVV-sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332324:Sensitive [Functional Concept]
   827   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "pepstatin/GVV-insensitive -secretase cleavages equivalently."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0010813:cleavage [Cell Function]
   766   C0596311:Cleavage [Phenomenon or Process]
   766   C1330957:cleavage [Cell Function]
Processing 00000000.tx.165: PS1 Mutants That Inhibit -Secretase Are Incorporated into High Molecular Weight Complexes-- One possible explanation for the inhibition of -secretase by these mutants is their ability to replace endogenous PS1 but not be incorporated into functional high molecular weight complexes. 

Phrase: "PS1 Mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "That"

Phrase: "Inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Are"

Phrase: "Incorporated into High Molecular Weight Complexes"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   783   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705104:Weight [Idea or Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "--"

Phrase: "One possible explanation for the inhibition of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681841:Explanation [Intellectual Product]

Phrase: "by these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "endogenous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "incorporated into functional high molecular weight complexes."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C1979900:High molecular weight [Qualitative Concept]
   778   C0026385:Molecular Weight [Quantitative Concept]
   774   C0948775:high weight [Sign or Symptom]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0205245:Functional [Functional Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0542341:Functional [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1704241:Complexes [Chemical Viewed Structurally]
   748   C1705104:Weight [Idea or Concept]
   748   C2700149:HIGH [Intellectual Product]
   748   C2700217:Functional [Conceptual Entity]
   714 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.166: To explore this possibility, we examined digitonin lysates from PS1wt, TM1-2, and D385A cell lines by glycerol density gradient centrifugation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "digitonin lysates from PS1wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881488:Lysate [Physical Object]

Phrase: "TM1-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "D385A cell lines by glycerol density gradient centrifugation."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0007600:Cell lines [Cell]
   767   C0162339:Cell Density [Quantitative Concept]
   744   C0007634:Cell [Cell]
   744   C0205132:lines [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.167: To facilitate analysis, lysates from cells expressing the PS1 wild-type protein were used as an internal control and combined with an equal amount of lysate from the TM1-2 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "lysates from cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "expressing"

Phrase: "the PS1 wild-type protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "used as an internal control"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0597937:internal control [Mental Process]
   760   C0205102:Internal [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1550141:Control [Substance]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "combined with an equal amount of lysate"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0205163:Equal [Qualitative Concept]
   748   C0205195:Combined [Qualitative Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1549782:Equal [Idea or Concept]
   748   C1881488:Lysate [Physical Object]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "from the TM1-2 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.168: Analysis of these gradients revealed that the full-length TM1-2 was incorporated into a defined complex with an apparent molecular mass of ~150-250 kDa (Fig. 6). 

Phrase: "Analysis of these gradients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the full-length TM1-2"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   875   C0806636:Length 2 [Quantitative Concept]
   812   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]
   812   C0443225:Full [Qualitative Concept]
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "incorporated into a defined complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "with an apparent molecular mass of ~150-250 kDa (Fig. 6"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   807   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   791   C0349966:Fig [Food]
   791   C0577559:Mass [Finding]
   791   C0750489:apparent [Idea or Concept]
   791   C1306372:*Mass [Quantitative Concept]
   791   C1337208:FIG [Food]
   791   C1521991:Molecular [Qualitative Concept]
   791   C1532717:kDa [Quantitative Concept]
   720 E C0567416:Molecule [Substance]

Phrase: ")."
Processing 00000000.tx.169: Similar results were obtained for the D385A cell lines (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for the D385A cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1301820:Obtained [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: Both mutant proteins were distributed in a comparable manner to that of the PS1wt holoprotein. 

Phrase: "Both mutant proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "distributed in a comparable manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704711:Distributed [Functional Concept]

Phrase: "to that"

Phrase: "of the PS1wt holoprotein."
Processing 00000000.tx.171: In these gradients, the endoproteolytic fragments overlapped with the holoproteins, making it difficult to discern if the mutant complex was completely matured. 

Phrase: "In these gradients,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "the endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "overlapped with the holoproteins,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0185027:overlapped [Therapeutic or Preventive Procedure]
   737 E C1948020:Overlap [Conceptual Entity]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "discern"

Phrase: "if"

Phrase: "the mutant complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "matured."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205286:Mature [Temporal Concept]
Processing 00000000.tx.172: Although additional studies may be required to ascertain whether this represents a fully functional complex, the mutants were not abnormally distributed and appeared to be handled similar to the wild-type protein. 

Phrase: "Although"

Phrase: "additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "this"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a fully functional complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "the mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "not abnormally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "handled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708320:Handle [Conceptual Entity]

Phrase: "similar to the wild-type protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.173: View larger version (58K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 6.  

Phrase: "6."
Processing 00000000.tx.175: Mutant PS1 is incorporated into high molecular weight complexes. 

Phrase: "Mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "incorporated into high molecular weight complexes."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   783   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705104:Weight [Idea or Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.176: Glycerol velocity gradient centrifugation of TM1-2. 

Phrase: "Glycerol velocity gradient centrifugation of TM1-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0007703:Centrifugation [Laboratory Procedure]
Processing 00000000.tx.177: Digitonin lysates were separated on a linear glycerol gradient and SDS-polyacrylamide gel electrophoresis as described (29). 

Phrase: "Digitonin lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "separated on a linear glycerol gradient"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0086972:Separated [Finding]
   753   C0205132:Linear [Spatial Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C0812409:Gradient [Quantitative Concept]

Phrase: "and"

Phrase: "SDS-polyacrylamide gel electrophoresis as described"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.178: Immunoblots were probed with antibody NT1 to PS1 residues 41-49 (29). 

Phrase: "Immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "were"

Phrase: "probed with antibody NT1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "to PS1 residues 41-49"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.179: The incorporation of the TM1-2 PS1 mutant into high molecular weight complexes was essentially unchanged from that of PS1wt. 

Phrase: "The incorporation of the TM1-2 PS1 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243126:incorporation [Functional Concept]

Phrase: "into high molecular weight complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "was"

Phrase: "essentially unchanged from that of PS1wt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442739:Unchanged [Finding]
   753   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.180: PS1 Aspartate Mutants do Not Augment Inducible -Secretase Cleavage-- Although a role of PSs in regulating -secretase activity is well established, several studies also suggest that PS1 may regulate the phorbol ester-inducible -secretase cleavage that appears to be carried out by members of the ADAM family of metalloproteases (30-32). 

Phrase: "PS1 Aspartate Mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "do"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "Inducible -Secretase Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "-"

Phrase: "-"

Phrase: "Although"

Phrase: "a role of PSs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating -"

Phrase: "secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "well established, several studies also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "may"

Phrase: "regulate"

Phrase: "the phorbol ester-inducible -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0010813:cleavage [Cell Function]
   804   C0596311:Cleavage [Phenomenon or Process]
   804   C1330957:cleavage [Cell Function]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by members of the ADAM family of metalloproteases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   762   C0086282:Family Members [Family Group]
   745 E C1611821:Family Member [Intellectual Product]
   742   C0015576:Family [Family Group]
   742   C0025543:Metalloproteases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0439787:Out [Spatial Concept]
   742   C0680022:members [Population Group]
   742   C0849355:Out [Qualitative Concept]
   742   C1704727:Family [Conceptual Entity]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "(30-32"

Phrase: ")."
Processing 00000000.tx.181: Two studies showed that overexpression of PS1 augments inducible -secretase cleavage of APP, whereas overexpression of FAD-linked mutant PS1 does not (31, 32). 

Phrase: "Two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that overexpression of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "inducible -secretase cleavage of APP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "whereas"

Phrase: "overexpression of FAD-linked mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "does"

Phrase: "not (31,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450355:31 [Intellectual Product]
   861   C1518422:Not [Functional Concept]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.182: Additionally, PS1 knockout abolishes inducible -secretase cleavage of APP (30). 

Phrase: "Additionally,"

Phrase: "PS1 knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "abolishes"

Phrase: "inducible -secretase cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.183: To determine whether PS1 aspartate mutants also inhibit inducible -secretase cleavage, wild-type CHO and HEK lines were compared with those overexpressing PS1wt, M139V, Asp-257, or D385E treated with 1M of the phorbol ester compounds phorbol 12-myristate 13-acetate or PDBu for 4-6 h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "PS1 aspartate mutants also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "inducible -secretase cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "wild-type CHO"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0324936:Wild hamster, NOS [Mammal]
   840   C0018555:Chinese Hamster [Mammal]
   804   C0008120:chinese [Language]
   804   C0018557:Hamster [Mammal]
   804   C0029939:Ovary [Body Part, Organ, or Organ Component]
   804   C0152035:Chinese [Population Group]
   804   C0227898:ovary [Body Part, Organ, or Organ Component]
   804   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "HEK lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "compared with those overexpressing PS1wt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1707455:Compared [Activity]
   726   C1514559:overexpress [Genetic Function]

Phrase: "M139V,"

Phrase: "Asp-257,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "or"

Phrase: "D385E"

Phrase: "treated with 1M"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0470296:1M [Quantitative Concept]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "of the phorbol ester compounds phorbol 12-myristate 13-acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   894   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   793   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   703   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "or"

Phrase: "PDBu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "PDBu for 4-6 h."
Processing 00000000.tx.184: CHO cells were transiently transfected with APP695wt, and sAPP was measured by ELISA (not shown), whereas endogenous levels of sAPP were evaluated in HEK cells following metabolic labeling with [35S]methionine and IP with Ab207 (Fig. 7). 

Phrase: "CHO cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with APP695wt,"

Phrase: "and"

Phrase: "sAPP"

Phrase: "was"

Phrase: "measured by ELISA"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "endogenous levels of sAPP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "evaluated in HEK cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cells [Cell]
   770   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C0220825:Evaluated [Functional Concept]
   770   C0812263:HEK [Gene or Genome]
   770   C1704817:HEK [Gene or Genome]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "metabolic labeling with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1167624:Labeling [Mental Process]
   790   C1947902:Labeling [Manufactured Object]
   790   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP with Ab207"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.185: As is the case with the PS1 FAD-linked M139V mutation, the PS aspartate mutants abolish the effect of PS overexpression on phorbol ester treatment. 

Phrase: "As is"

Phrase: "the case with the PS1 FAD-linked M139V mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0868928:Case [Functional Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]

Phrase: "the PS aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "abolish"

Phrase: "the effect of PS overexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on phorbol ester treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.186: View larger version (62K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(62K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.187: 7.  

Phrase: "7."
Processing 00000000.tx.188: PS1 mutations attenuate inducible -secretase activity. 

Phrase: "PS1 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "inducible -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.189: A, pooled stable HEK293 cell lines were labeled, treated with PDBu (+) or vehicle alone (), and serum-free-conditioned media was collected and endogenous sAPP was immunoprecipitated with Ab207. 

Phrase: "A,"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "stable HEK293 cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   861   C2936239:HEK293 Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "treated with PDBu"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0031588:phorbol [Organic Chemical]
   770   C0070750:Phorbol [Organic Chemical]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "PDBu"

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "serum-free-conditioned media"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C1254021:Media [Tissue]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "endogenous sAPP"

Phrase: "was"

Phrase: "immunoprecipitated with Ab207."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.190: The experiment was performed twice, in triplicate; 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "twice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "in triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.191: a representative 7-day phosphorimage is shown. 

Phrase: "a representative 7-day phosphorimage"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.192: B, sAPP bands from PDBu-treated cells were quantified, expressed as a percentage of control sAPP, and compared with PS1wt values by analysis of variance followed by Dunnett's test. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "sAPP bands from PDBu"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "PDBu-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "quantified"

Phrase: ","

Phrase: "expressed as a percentage of control sAPP,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "compared with PS1wt values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0042295:Values [Qualitative Concept]
   770   C1707455:Compared [Activity]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "by analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of variance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1711260:Variance [Qualitative Concept]
  1000   C2348152:Variance [Quantitative Concept]
   928 E C0205419:Variant [Qualitative Concept]

Phrase: "followed by Dunnett's test."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.193: There were no significant differences between the two experiments, and constitutive levels of sAPP did not differ between the various cell lines. 

Phrase: "There"

Phrase: "were"

Phrase: "no significant differences between the two experiments,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "constitutive levels of sAPP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between the various cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.194: Overexpression of PS1wt potentiated the effect of PDBu on sAPP secretion, whereas overexpression of mutant forms of PS1 (both aspartate mutant and the FAD-linked M139V) did not (*=p<0.05; **=p<0.01).  

Phrase: "Overexpression of PS1wt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "potentiated"

Phrase: "the effect of PDBu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "PDBu on sAPP secretion,"

Phrase: "whereas"

Phrase: "overexpression of mutant forms of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "("

Phrase: "both aspartate mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the FAD-linked M139V"

Phrase: ")"

Phrase: "did"

Phrase: "not (*=p<0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1518422:Not [Functional Concept]

Phrase: ";"

Phrase: "*"

Phrase: "*"

Phrase: "=p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.195: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The study of -secretase activity using the substrate-based inhibitor GVV further extends and confirms our previous observations that there are at least two distinct -secretase activities (11): a -40 activity, which cleaves more proximal to the ectodomain of APP and is more sensitive to these inhibitors, and a -42 activity, which cleaves more distal residues and is less sensitive. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The study of -secretase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C2348552:Study Activity [Research Activity]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the substrate-based inhibitor GVV further"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "and"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "our previous observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that there"

Phrase: "are at least two distinct -secretase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205448:Two [Quantitative Concept]
   748   C0441655:Activities [Activity]
   748   C1551058:Are [Quantitative Concept]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ":"

Phrase: "a -40 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "cleaves"

Phrase: "more proximal to the ectodomain of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205107:Proximal [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "more sensitive to these inhibitors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "a -42 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "cleaves"

Phrase: "more distal residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "less sensitive."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.196: Based on these data we have explored the regulation of these distinct -secretase activities by PS1 mutants. 

Phrase: "Based on these data"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "have"

Phrase: "explored"

Phrase: "the regulation of these distinct -secretase activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by PS1 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.197: As previously reported, we have found that expression of PS1 aspartate mutants inhibit -secretase cleavage of APP CTF (33). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that expression of PS1 aspartate mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase cleavage of APP CTF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597304:Protein Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.198: In addition, we have identified two other PS1 mutants whose expression inhibits A production. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "whose expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.199: Both PS1 out and TM1-2 mutants inhibit -secretase as effectively or more effectively than the PS1 DA/E mutants indicating (i) that the position of the aspartates within presumptive transmembrane domains is critical for proper PS1 function and (ii) that the alterations of PS1 structure at sites relatively distant from the hypothesized "active site" can result in an apparent dominant-negative effect on -secretase activity. 

Phrase: "Both PS1 out"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "TM1-2 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "effectively"

Phrase: "or"

Phrase: "more effectively than the PS1 DA/E mutants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205172:More [Functional Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596988:mutants [Cell or Molecular Dysfunction]
   744   C1418985:PS1 [Gene or Genome]
   744   C2986918:PS1 [Gene or Genome]

Phrase: "indicating (i)"

Phrase: "that"

Phrase: "the position of the aspartates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:Position [Spatial Concept]

Phrase: "within presumptive transmembrane domains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "critical for proper PS1 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "that"

Phrase: "the alterations of PS1 structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "relatively distant from the hypothesized ""active site"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443203:Distant [Spatial Concept]

Phrase: "can"

Phrase: "result in an apparent dominant-negative effect on -secretase activity."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   739   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205160:Negative [Qualitative Concept]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0750489:apparent [Idea or Concept]
   739   C1274040:Result [Functional Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C1513916:Negative [Finding]
   739   C1527180:Dominant [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1561536:*Activity [Idea or Concept]
   739   C2348382:Effect [Qualitative Concept]
   739   C2825142:Result [Finding]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.200: Though there is no definitive evidence that identifies the mechanisms by which these mutant PS1 proteins inhibit -secretase activity, the finding that these proteins can replace endogenous PS1 and are incorporated into high molecular weight complexes is consistent with the proposed dominant-negative mechanism of action, although additional experiments will clearly be needed to support that claim. 

Phrase: "Though"

Phrase: "there"

Phrase: "is"

Phrase: "no definitive evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "identifies"

Phrase: "the mechanisms by which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "these mutant PS1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "endogenous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "are"

Phrase: "incorporated into high molecular weight complexes"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   783   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705104:Weight [Idea or Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "is"

Phrase: "consistent with the proposed dominant-negative mechanism of action,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "although"

Phrase: "additional experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "will"

Phrase: "clearly"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "that claim."
Processing 00000000.tx.201: Furthermore, we did not observe a consistent absence of PS1 endoproteolysis accompanying the decrease in A production (e.g. with TM1-2), indicating that this effect may not be related to PS1 holoprotein cleavage as was previously implied (14). 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a consistent absence of PS1 endoproteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "accompanying"

Phrase: "the decrease in A production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: "with TM1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0387008:TM 1 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "related to PS1 holoprotein cleavage"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0010813:cleavage [Cell Function]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "as"

Phrase: "was"

Phrase: "previously"

Phrase: "implied"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.202: This is consistent with other findings that the pathological effect of the PS1 exon 9mutation is not related to the defect in endoproteolysis exhibited by this mutant (13, 34). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with other findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that"

Phrase: "the pathological effect of the PS1 exon 9mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to the defect"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in endoproteolysis"

Phrase: "exhibited by this mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   737   C0015272:Exhibit [Intellectual Product]

Phrase: "(13,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.203: Our finding that distinct -40 and -42 activities are equally inhibited by PS1 aspartate mutants is difficult to reconcile with the hypothesis that PS1 is a -secretase with active site residues at Asp-257 and Asp-385. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that distinct -40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "and -"

Phrase: "42 activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "equally"

Phrase: "inhibited by PS1 aspartate mutants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0332218:Difficult [Qualitative Concept]
   761 E C1299586:Difficulty [Finding]

Phrase: "reconcile with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1960278:RECONCILE [Organic Chemical,Pharmacologic Substance]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "a -secretase with active site residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at Asp-257"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "and"

Phrase: "Asp-385."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]
Processing 00000000.tx.204: Based on data in this report and our previous studies of these APP TMD mutants, if PSs were novel intramembranous aspartic proteases responsible for -secretase cleavage, we would predict that the effects of these mutations on A production would be quite different from those observed. 

Phrase: "Based on data"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   841   C0242356:data base [Intellectual Product]
   841   C0993637:Data Base [Intellectual Product]
   790   C1511726:Data [Idea or Concept]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C3245479:data [Medical Device]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "our previous studies of these APP TMD mutants,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0947630:studies [Laboratory Procedure]
   704 E C0557651:Study [Manufactured Object]
   704 E C2603343:Study [Research Activity]

Phrase: "if"

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "novel intramembranous aspartic proteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Proteases [Enzyme]

Phrase: "responsible for -secretase cleavage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "would"

Phrase: "predict"

Phrase: "that"

Phrase: "the effects of these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "would"

Phrase: "be"

Phrase: "quite different from those observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.205: Instead of inhibiting all cleavages to a similar extent, they would only inhibit cleavage at pepstatin/GVV-sensitive sites. 

Phrase: "Instead of inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "all cleavages to a similar extent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0010813:cleavage [Cell Function]
   719   C0596311:Cleavage [Phenomenon or Process]
   719   C1330957:cleavage [Cell Function]

Phrase: "they"

Phrase: "would"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cleavage at pepstatin/GVV-sensitive sites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
Processing 00000000.tx.206: To illustrate this it is useful to focus on the I637P APP mutant. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "illustrate"

Phrase: "this it"

Phrase: "is"

Phrase: "useful to focus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0042153:use [Functional Concept]
   718   C0457083:Use [Functional Concept]
   718   C1947944:Use [Intellectual Product]

Phrase: "on the I637P APP mutant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.207: The PS1 mutants used in this study decrease both the pepstatin/GVV-sensitive cleavage at A37 and the pepstatin/GVV-insensitive cleavage at A43 to an equal extent, a finding that contrasts dramatically with the effects of both pepstatin and GVV treatment, which slightly decreases A37 production and increased A43 production. 

Phrase: "The PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "used in this study decrease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "both the pepstatin/GVV-sensitive cleavage at A37"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "the pepstatin/GVV-insensitive cleavage at A43"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "to an equal extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "contrasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "dramatically with the effects of both pepstatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "GVV treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "which slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A37 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "increased A43 production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]
Processing 00000000.tx.208: It should be mentioned that it is not possible to easily account for these data by postulating that PS1 is one -secretase and PS2 is the other, because knockout of either PS1 (which reduces both A40 and A42 equally) or PS2 (which has no effect on either A species) does not specifically alter -40 or -42 activity (13, 34). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "mentioned"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not possible to easily"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0332149:Possible [Qualitative Concept]
   812   C0332219:Easily [Qualitative Concept]
   812   C1518422:Not [Functional Concept]
   812   C1705910:Possible [Qualitative Concept]
   812   C2362652:Possible [Qualitative Concept]

Phrase: "account for these data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1511726:Data [Idea or Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   770   C3245479:data [Medical Device]

Phrase: "by postulating"

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "one -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PS2"

Phrase: "is"

Phrase: "the other,"

Phrase: "because"

Phrase: "knockout of either PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0560617:knock out [Injury or Poisoning]
   770   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "("

Phrase: "which"

Phrase: "reduces"

Phrase: "both A40"

Phrase: "and"

Phrase: "A42 equally"

Phrase: ")"

Phrase: "or"

Phrase: "PS2"

Phrase: "("

Phrase: "which"

Phrase: "has"

Phrase: "no effect on either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: ")"

Phrase: "does"

Phrase: "not specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "40 or -42 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(13,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.209: Of course, it is still possible that PS1 is -secretase, but for this to be the case then they must have either multiple active sites or multiple active conformations. 

Phrase: "Of course,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "it"

Phrase: "is"

Phrase: "still possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that PS1 is -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but for this to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the case then"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "they"

Phrase: "must"

Phrase: "have"

Phrase: "either multiple active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0205681:Sites, Active [Functional Concept]
   812   C0205145:Sites [Spatial Concept]
   812   C0205177:Active [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "multiple active conformations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.210: In any case, one of these sites or conformations must then be responsible for the -40 activity and the other for the -42 activity. 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "one of these sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0026377:Conformation [Spatial Concept]

Phrase: "must"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "responsible for the -40 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "the other for the -42 activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.211: Given that PSs have no homology to any known protease, if PSs contain the active site(s) of -secretase then they represent a truly unprecedented class of proteolytic enzyme. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "no homology to any known protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]

Phrase: "if"

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s)"

Phrase: "of -secretase then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "they"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a truly unprecedented class of proteolytic enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456387:Class [Intellectual Product]
   748   C1705943:Class [Classification]
Processing 00000000.tx.212: Furthermore, based on some of the same criteria that have lent credence to the PS-as--secretase hypothesis (e.g. PS1 knockout and the effect of aspartate mutants on -cleavage), one could postulate that PSs are also the inducible -secretase enzymes. 

Phrase: "Furthermore,"

Phrase: "based on some of the same criteria"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0243161:criteria [Intellectual Product]
   748   C0445247:Same [Qualitative Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "have"

Phrase: "lent credence to the PS-as--secretase hypothesis"

Phrase: "("

Phrase: "e.g. PS1 knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "and"

Phrase: "the effect of aspartate mutants on -cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "postulate"

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "also"

Phrase: "the inducible -secretase enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.213: This is obviously extremely unlikely, because two of the enzymes (TACE and ADAM-10) at least partially responsible for inducible -secretase activity have been identified (9, 10). 

Phrase: "This"

Phrase: "is"

Phrase: "obviously extremely unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0750558:Unlikely [Conceptual Entity]
   827   C1710571:Unlikely [Qualitative Concept]

Phrase: "because"

Phrase: "two of the enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "(TACE"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0723595:Tace [Hormone,Pharmacologic Substance,Steroid]
  1000   C0796679:TACE [Therapeutic or Preventive Procedure]
  1000   C1412186:TACE [Gene or Genome]
  1000   C1706640:TACE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539919:TACE [Therapeutic or Preventive Procedure]
   944 E C0008275:Chlorotrianisene [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ADAM-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "at least partially responsible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1273518:Responsible [Finding]

Phrase: "for inducible -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.214: If PSs are not -secretase, then how might they influence both the inducible -secretase cleavage of APP and distinct -secretase activities? 

Phrase: "If"

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "not -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "then how"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "might"

Phrase: "they"

Phrase: "influence"

Phrase: "both the inducible -secretase cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597304:Protein Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "distinct -secretase activities?"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.215: We cannot rule out the possibility that PSs are proteases that cleave and activate multiple pharmacologically distinct -secretases and/or inducible -secretases in an upstream manner. 

Phrase: "We"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "that"

Phrase: "cleave"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "multiple pharmacologically distinct -secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and/or"

Phrase: "inducible -secretases in an upstream manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.216: However, in the absence of any direct evidence that PSs have proteolytic activity of any sort, we also find this explanation unlikely. 

Phrase: "However,"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of any direct evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "proteolytic activity of any sort,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0597304:Proteolytic [Molecular Function]
   760   C1561536:*Activity [Idea or Concept]
   760   C1947941:proteolytic [Enzyme]

Phrase: "we also"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "this explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681841:Explanation [Intellectual Product]

Phrase: "unlikely."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]
Processing 00000000.tx.217: PSs could play a role in "positioning" APP for inducible -secretase cleavage and APP CTF for -secretase cleavage, but evidence for an interaction of PS with mature APP (the substrate for -secretase cleavage) and APP CTF (the substrate for -cleavage) is inconsistent (19, 35, 36). 

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in ""positioning"" APP for inducible -secretase cleavage"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   786   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   786   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   770   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   754   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APP CTF for -secretase cleavage,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   745   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "evidence for an interaction of PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with mature APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "the substrate for -secretase cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "APP CTF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "the substrate for -cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: ")"

Phrase: "is"

Phrase: "inconsistent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442809:Inconsistent [Qualitative Concept]

Phrase: "(19,"

Phrase: "35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.218: It is possible that PSs are essential cofactors or chaperones for proteases involved in APP cleavage. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "essential cofactors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178555:cofactors [Biologically Active Substance]

Phrase: "or"

Phrase: "chaperones for proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in APP cleavage."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0010813:cleavage [Cell Function]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1330957:cleavage [Cell Function]
   753   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.219: If this is the case, then they must presumably interact not only with several -secretases but also with the proteases responsible for phorbol ester-inducible -secretase activity. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "they"

Phrase: "must"

Phrase: "presumably"

Phrase: "interact"

Phrase: "not only with several -secretases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also with the proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1947941:Proteases [Enzyme]

Phrase: "responsible for phorbol ester-inducible -secretase activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.220: Yet another possibility is that PSs play a role in the normal trafficking of APP CTF after constitutive cleavage by - and -secretase and are also required for appropriate trafficking of APP to the site where phorbol ester-inducible -secretase cleavage occurs. 

Phrase: "Yet"

Phrase: "another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "trafficking of APP CTF"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   800   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0599895:Protein Trafficking [Cell Function]
   767   C1159772:Protein Trafficking [Cell Function]
   750   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205088:Terminal [Temporal Concept]
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C0596260:Carboxyl [Organic Chemical]
   744   C0599896:trafficking [Cell Function]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1709634:Precursor [Idea or Concept]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "after constitutive cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "by -"

Phrase: "and -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "are"

Phrase: "also"

Phrase: "required for appropriate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1514873:Required [Functional Concept]
   790   C1548787:Appropriate [Qualitative Concept]
   718 E C0814634:appropriateness [Qualitative Concept]

Phrase: "trafficking of APP"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0599895:Protein Trafficking [Cell Function]
   797   C1159772:Protein Trafficking [Cell Function]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0599896:trafficking [Cell Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "to the site where phorbol ester-inducible -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0010813:cleavage [Cell Function]
   795   C0596311:Cleavage [Phenomenon or Process]
   795   C1330957:cleavage [Cell Function]

Phrase: "occurs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.221: Both of these latter possibilities are consistent with hypothesized roles of PSs in trafficking a select set of membrane proteins (19, 37). 

Phrase: "Both of these latter possibilities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]

Phrase: "are"

Phrase: "consistent with hypothesized roles of PSs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "a"

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "set of membrane proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "(19,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.222: Although no alterations in the subcellular distribution of APP have yet been observed in PS1 knockout cells, the amount of APP destined for processing either to A or by inducible -secretase activity is by most estimates only a relatively small fraction of total cellular APP. 

Phrase: "Although"

Phrase: "no alterations in the subcellular distribution of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1515926:Alteration [Idea or Concept]

Phrase: "have"

Phrase: "yet"

Phrase: "been"

Phrase: "observed in PS1 knockout cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0007634:Cells [Cell]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1418985:PS1 [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C1522225:Knock-out [Experimental Model of Disease]
   760   C2986918:PS1 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the amount of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "destined for processing either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "to A"

Phrase: "or by inducible -secretase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0205263:Inducible [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is by most"

Phrase: "estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a relatively small fraction of total cellular APP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0439162:Fraction of total protein [Quantitative Concept]
   782   C0439160:Fraction of total [Quantitative Concept]
   760   C1264633:Fraction of [Quantitative Concept]
           Fraction
   739   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.223: If PSs function in this manner, they are likely to regulate a specific pool of APP and APP CTF and alterations may not be readily apparent in relatively crude subcellular fractionation studies. 

Phrase: "If"

Phrase: "PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "function in this manner,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "they"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "regulate"

Phrase: "a specific pool of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0337051:Pool [Geographic Area]
   748   C1509144:pool [Clinical Attribute]
   748   C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "APP CTF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "readily apparent in relatively crude subcellular fractionation studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.224: Ultimately, to settle the question of whether or not PSs are -secretase, it will be necessary to either (i) prove that PSs are catalytic by showing that the purified protein has -activity or (ii) show that another protease catalyzes -cleavage. 

Phrase: "Ultimately,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "settle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1266099:SETTLE [Neoplastic Process]

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "or"

Phrase: "not PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are -"

Phrase: "secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "necessary to either"

Phrase: "("

Phrase: "i"

Phrase: ")"

Phrase: "prove"

Phrase: "that PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "catalytic by showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007382:Catalytic [Natural Phenomenon or Process]

Phrase: "that"

Phrase: "the purified protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has -"

Phrase: "activity or (ii"

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "another protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "catalyzes -"

Phrase: "cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]
Processing 00000000.tx.225: Nevertheless, given the evidence for complex interaction of PSs with a growing list of important cellular proteins, including several catenins (28, 38-41), Bcl-X-L (42), Notch (16-18, 43, 44) GSK3 (41, 45), rab GDP dissociation inhibitor (46), E-cadherin (47), and a potential functional role in the unfolded protein response (48, 49), specific targeting of the A-regulating activity of PSs may prove very difficult.  

Phrase: "Nevertheless,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the evidence for complex interaction of PSs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with a growing list"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0745732:List [Conceptual Entity]
   861   C3272378:LIST [Intellectual Product]

Phrase: "of important cellular proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "several catenins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1564904:Catenins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(28,"

Phrase: "38-41"

Phrase: ")"

Phrase: ","

Phrase: "Bcl-X-L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0219472:BCL-X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332397:BCLX [Gene or Genome]
   901   C1704960:BCLX [Gene or Genome]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "(16-18,"

Phrase: "43,"

Phrase: "44"

Phrase: ")"

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(41,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "rab GDP dissociation inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0752093:GDP Dissociation Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1999216:Inhibitor [Qualitative Concept]
   756   C1415039:rab GDP-dissociation [Gene or Genome]
   756   C1415040:rab GDP-dissociation [Gene or Genome]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a potential functional role in the unfolded protein response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1705810:Functional Role [Conceptual Entity]
           Role
   742   C0035820:Role [Social Behavior]

Phrase: "(48,"

Phrase: "49"

Phrase: ")"

Phrase: ","

Phrase: "specific targeting of the A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1521840:Targeting [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "regulating"

Phrase: "activity of PSs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "prove"

Phrase: "very difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]
Processing 00000000.tx.226: ACKNOWLEDGEMENTS Antibody 207was kindly provided by B.

Phrase: "ACKNOWLEDGEMENTS Antibody 207was kindly"

Phrase: "provided by B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.227: Greenberg; 

Phrase: "Greenberg"

Phrase: ";"
Processing 00000000.tx.228: BC05, BAN50, and BA27 were gifts of Takeda industries; 

Phrase: "BC05,"

Phrase: "BAN50,"

Phrase: "and"

Phrase: "BA27"

Phrase: "were"

Phrase: "gifts of Takeda industries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021267:Industries [Occupational Activity]
   770   C1136188:Gifts [Entity]

Phrase: ";"
Processing 00000000.tx.229: CT20 was provided by K.

Phrase: "CT20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1842761:CT20 [Gene or Genome]

Phrase: "was"

Phrase: "provided by K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1708601:K' [Quantitative Concept]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.230: Sambamurti (Mayo); 

Phrase: "Sambamurti"

Phrase: "(Mayo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0454788:Mayo [Geographic Area]
  1000   C1077578:mayo [Plant]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.231: anti-PS1 loop and PS1-N were provided by G.

Phrase: "anti-PS1 loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "PS1-N"

Phrase: "were"

Phrase: "provided by G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439267:g% [Quantitative Concept]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.232: Thinakaran (University of Chicago); 

Phrase: "Thinakaran"

Phrase: "(University of Chicago"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.233: and NT1 was provided by Paul Matthews (Nathan Kline Institute).  

Phrase: "and"

Phrase: "NT1"

Phrase: "was"

Phrase: "provided by Paul Matthews"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "(Nathan Kline Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.234: Note Added in Proof Recently, it has been observed that high potency, photoactivated inhibitors of -secretase activity directed toward the active site of aspartyl proteases bind to PS1 (50). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Added in Proof Recently,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332185:Recently [Temporal Concept]
   770   C0556981:% proof [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that high potency,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   745   C3245505:Potential [Qualitative Concept]

Phrase: "photoactivated inhibitors of -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "directed toward the active site of aspartyl proteases"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0078989:aspartyl proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205681:Active Site [Functional Concept]
   770   C2717969:Aspartyl Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2945843:Site of [Qualitative Concept]
   744   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0205145:Site [Spatial Concept]
   744   C0205177:Active [Functional Concept]
   744   C1515974:Site [Body Location or Region]
   744   C1947941:Proteases [Enzyme]
   744   C2825164:Site [Spatial Concept]
   711   C0439851:Direct [Qualitative Concept]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "bind to PS1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.235: As this finding provides strong support that PS1 is a -secretase, this would favor the interpretation of our data that PS1 must exist in at least two distinct conformational states capable of generating distinct A species.  

Phrase: "As this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "strong"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442821:Strong [Qualitative Concept]
   928 E C0237897:Strength [Quantitative Concept]
   928 E C0808080:Strength [Idea or Concept]
   928 E C1705922:Strength [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "a -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "this"

Phrase: "would"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the interpretation of our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0459471:Interpretation [Intellectual Product]
   760   C3173575:Interpretation [Clinical Attribute]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "must"

Phrase: "exist in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2987476:Exist [Conceptual Entity]

Phrase: "at least two distinct conformational states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C1301808:states [Geographic Area]
   771 E C1442792:State [Functional Concept]
   771 E C3148680:State [Geographic Area]

Phrase: "capable of generating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "distinct"

Phrase: "A species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.236: FOOTNOTES * This work was supported in part by a Beeson Award from American Federation for Aging Research and an Ellison Medical Foundation New Scholars award (to T.E.G.), National Institutes of Health/National Institute on Aging Grant AG-16065 (to R.W.), and the Alzheimer's Society of Ontario and Medical Research Council (to P.E.F.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a Beeson Award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004446:Award [Manufactured Object]

Phrase: "from American Federation"

Phrase: "for Aging Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "an Ellison Medical Foundation New Scholars award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0004446:Award [Manufactured Object]

Phrase: "("

Phrase: "to T.E.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "National Institutes of Health/National Institute on Aging Grant AG-16065"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   857   C1955974:National Institute on Aging [Health Care Related Organization]
   832   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   794   C2963171:Healthy Aging [Group Attribute]
   788   C0001811:Ageing [Organism Function]
   788   C0018173:Grant [Quantitative Concept]
   788   C0018684:Health [Idea or Concept]
   788   C0021622:Institutes [Organization]
   788   C1548284:Grant [Idea or Concept]
   788   C3245503:national [Intellectual Product]
   755 E C0001779:Age [Organism Attribute]
   755 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to R.W."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Alzheimer's Society of Ontario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037455:society [Organization]

Phrase: "and"

Phrase: "Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "("

Phrase: "to P.E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.237: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.238: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.239: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.240: A John Douglas French Alzheimer's Foundation Fellow. 

Phrase: "A John Douglas French Alzheimer's Foundation Fellow."
Processing 00000000.tx.241: ** To whom correspondence should be addressed: Mayo Clinic Jacksonville, Dept. of Pharmacology, 4500San Pablo Rd., Jacksonville, FL 32224.Tel.: 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "Dept."

Phrase: "of Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "4500San Pablo Rd.,"

Phrase: "Jacksonville,"

Phrase: "FL 32224.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.242: 904-953-2538; 

Phrase: "904-953-2538"

Phrase: ";"
Processing 00000000.tx.243: Fax: 904-953-7370; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "904-953-7370"

Phrase: ";"
Processing 00000000.tx.244: E-mail: tgolde@mayo.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "tgolde@mayo.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.245: Published, JBC Papers in Press, May 17,2000,DOI 10.1074/jbc.M002812200 2 T. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "May 17,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M002812200 2 T."
Processing 00000000.tx.246: E.Golde, manuscript in preparation.  

Phrase: "E.Golde,"

Phrase: "manuscript in preparation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.247: ABBREVIATIONS The abbreviations used are: A, amyloid protein; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.248: PSs, presenilins; 

Phrase: "PSs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.249: APP, amyloid protein precursor; 

Phrase: "APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "amyloid protein precursor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.250: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.251: TMD, transmembrane domain; 

Phrase: "TMD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: "transmembrane domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.252: IP/MS, immunoprecipitation/mass spectrometry; 

Phrase: "IP/MS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "immunoprecipitation/mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.253: PDBu, phorbol 12,13-dibutyrate; 

Phrase: "PDBu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "PDBu,"

Phrase: "phorbol 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "13-dibutyrate"

Phrase: ";"
Processing 00000000.tx.254: CTF, carboxyl-terminal fragments; 

Phrase: "CTF,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "carboxyl-terminal fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.255: wt, wild-type; 

Phrase: "wt, wild-type"

Phrase: ";"
Processing 00000000.tx.256: CHO, Chinese hamster ovary; 

Phrase: "CHO,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.257: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.258: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.259: GVV, Boc-glycine-valine-valinal; 

Phrase: "GVV,"

Phrase: "Boc-glycine-valine-valinal"

Phrase: ";"
Processing 00000000.tx.260: ADAM, a disintegrin and metalloprotease; 

Phrase: "ADAM,"

Phrase: "a disintegrin and metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.261: PIC, protease inhibitor cocktail.  

Phrase: "PIC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "protease inhibitor cocktail."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678420:Cocktail [Food]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]
Processing 00000000.tx.262: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.263: Busciglio, J., Gabuzda, D., Matsudaira, P., and Yankner, B. 

Phrase: "Busciglio,"

Phrase: "J.,"

Phrase: "Gabuzda,"

Phrase: "D."

Phrase: ","

Phrase: "Matsudaira,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.264: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.265: Natl. 

Phrase: "Natl."
Processing 00000000.tx.266: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.267: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.268: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.269: 90, 2092-2096[Abstract] 2. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2092-2096"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.270: Haass, C., Schlossmacher, M. 

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.271: G., Hung, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.272: Y., Bigo-pelfrey, C., Mellon, A., Ostaszewski, B. 

Phrase: "Y.,"

Phrase: "Bigo-pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mellon,"

Phrase: "A.,"

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.273: L., Lieberburg, I., Koo, E. 

Phrase: "L., Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.274: H., Schenk, D., Teplow, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.275: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.276: J. 

Phrase: "J."
Processing 00000000.tx.277: (1992) Nature 359, 322-325[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 359,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "322-325"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.278: Shoji, M., Golde, T. 

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.279: E., Ghiso, J., Cheung, T. 

Phrase: "E.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.280: T., Estus, S., Shaffer, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Shaffer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.281: M., Cai, X., McKay, D. 

Phrase: "M."

Phrase: ","

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.,"

Phrase: "McKay,"

Phrase: "D."
Processing 00000000.tx.282: M., Tintner, R., Frangione, B., and Younkin, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tintner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.283: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.284: (1992) Science 258, 126-129[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "126-129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.285: Seubert, P., Oltersdorf, T., Lee, M. 

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: G., Barbour, R., Blomquist, C., Davis, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blomquist,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Davis,"

Phrase: "D."
Processing 00000000.tx.287: L., Bryant, K., Fritz, L. 

Phrase: "L., Bryant,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fritz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414819:FRITZ [Gene or Genome]
  1000   C2681211:fritz [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.288: C., Galasko, D., Thal, L. 

Phrase: "C., Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.289: J., Lieberburg, I., and Schenk, D. 

Phrase: "J.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.290: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.291: (1993) Nature 361, 260-263[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "260-263"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.292: Hussain, I., Powell, D., Howlett, D. 

Phrase: "Hussain,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Powell,"

Phrase: "D."

Phrase: ","

Phrase: "Howlett,"

Phrase: "D."
Processing 00000000.tx.293: R., Tew, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tew,"

Phrase: "D."
Processing 00000000.tx.294: G., Meek, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Meek,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.295: D., Chapman, C., Gloger, I. 

Phrase: "D."

Phrase: ","

Phrase: "Chapman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gloger,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.296: S., Murphy, K. 

Phrase: "S."

Phrase: ","

Phrase: "Murphy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.297: E., Southan, C. 

Phrase: "E.,"

Phrase: "Southan,"

Phrase: "C."
Processing 00000000.tx.298: D., Ryan, D. 

Phrase: "D."

Phrase: ","

Phrase: "Ryan,"

Phrase: "D."
Processing 00000000.tx.299: M., Smith, T. 

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.300: S., Simmons, D. 

Phrase: "S."

Phrase: ","

Phrase: "Simmons,"

Phrase: "D."
Processing 00000000.tx.301: L., Walsh, F. 

Phrase: "L., Walsh,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.302: S., Dingwall, C., and Christie, G. 

Phrase: "S."

Phrase: ","

Phrase: "Dingwall,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Christie,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.303: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.304: Cell Neurosci. 

Phrase: "Cell Neurosci."
Processing 00000000.tx.305: 14, 419-427[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "14,"

Phrase: "419-427"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.306: Vassar, R., Bennett, B., Babu-Khan, S., Rogers, G., and Citron, M. 

Phrase: "Vassar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bennett,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Babu-Khan,"

Phrase: "S."

Phrase: ","

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.307: (1999) Science 286, 735-740[Abstract/Free FullText] 7. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "735-740"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.308: Sinha, S., Anderson, J. 

Phrase: "Sinha,"

Phrase: "S."

Phrase: ","

Phrase: "Anderson,"

Phrase: "J."
Processing 00000000.tx.309: P., Barbour, R., Basi, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Basi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.310: S., Caccavello, R., Davis, D., Doan, M., Dovey, H. 

Phrase: "S."

Phrase: ","

Phrase: "Caccavello,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "D."

Phrase: ","

Phrase: "Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "M."

Phrase: ","

Phrase: "Dovey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.311: F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Frigon,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hong,"

Phrase: "J.,"

Phrase: "Jacobson-Croak,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jewett,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Keim,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Knops,"

Phrase: "J.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "M."

Phrase: ","

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tatsuno,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tung,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330603:Tung [Plant]

Phrase: "J.,"

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Suomensaari,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.312: M., Wang, S., Walker, D., and John, V. 

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "S."

Phrase: ","

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "John,"

Phrase: "V."
Processing 00000000.tx.313: (1999) Nature 402, 537-540[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 402,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "537-540"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.314: Yan, R., Bienkowski, M. 

Phrase: "Yan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bienkowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.315: J., Shuck, M. 

Phrase: "J.,"

Phrase: "Shuck,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.316: E., Miao, H., Tory, M. 

Phrase: "E.,"

Phrase: "Miao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tory,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.317: C., Pauley, A. 

Phrase: "C., Pauley,"

Phrase: "A."
Processing 00000000.tx.318: M., Brashier, J. 

Phrase: "M."

Phrase: ","

Phrase: "Brashier,"

Phrase: "J."
Processing 00000000.tx.319: R., Stratman, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stratman,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.320: C., Mathews, W. 

Phrase: "C., Mathews,"

Phrase: "W."
Processing 00000000.tx.321: R., Buhl, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Buhl,"

Phrase: "A."
Processing 00000000.tx.322: E., Carter, D. 

Phrase: "E.,"

Phrase: "Carter,"

Phrase: "D."
Processing 00000000.tx.323: B., Tomasselli, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tomasselli,"

Phrase: "A."
Processing 00000000.tx.324: G., Parodi, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Parodi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681440:parodi [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.325: A., Heinrikson, R. 

Phrase: "A.,"

Phrase: "Heinrikson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.326: L., and Gurney, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gurney,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150789:gurney [Medical Device]
  1000   C0183644:Gurney [Medical Device]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.327: E. 

Phrase: "E."
Processing 00000000.tx.328: (1999) Nature 402, 533-537[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 402,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "533-537"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.329: Buxbaum, J. 

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.330: D., Liu, K. 

Phrase: "D."

Phrase: ","

Phrase: "Liu,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.331: N., Luo, Y., Slack, J. 

Phrase: "N., Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.332: L., Stocking, K. 

Phrase: "L., Stocking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0453908:Stocking [Manufactured Object]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.333: L., Peschon, J. 

Phrase: "L., Peschon,"

Phrase: "J."
Processing 00000000.tx.334: J., Johnson, R. 

Phrase: "J.,"

Phrase: "Johnson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.335: S., Castner, B. 

Phrase: "S."

Phrase: ","

Phrase: "Castner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.336: J., Cerretti, D. 

Phrase: "J.,"

Phrase: "Cerretti,"

Phrase: "D."
Processing 00000000.tx.337: P., and Black, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: A. 

Phrase: "A."
Processing 00000000.tx.339: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.340: Biol. 

Phrase: "Biol."
Processing 00000000.tx.341: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.342: 273, 27765-27767[Abstract/Free FullText] 10. 

Phrase: "273,"

Phrase: "27765-27767"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.343: Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. 

Phrase: "Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Kojro,"

Phrase: "E.,"

Phrase: "Postina,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Pfeiffer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jasionowski,"

Phrase: "M."

Phrase: ","

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Fahrenholz,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.344: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.345: Natl. 

Phrase: "Natl."
Processing 00000000.tx.346: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.347: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.348: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.349: 96, 3922-3927[Abstract/Free FullText] 11. 

Phrase: "96,"

Phrase: "3922-3927"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.350: Murphy, M. 

Phrase: "Murphy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: P., Hickman, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hickman,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.352: J., Eckman, C. 

Phrase: "J.,"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.353: B., Uljon, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Uljon,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.354: N., Wang, R., and Golde, T. 

Phrase: "N., Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.355: E. 

Phrase: "E."
Processing 00000000.tx.356: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.357: Biol. 

Phrase: "Biol."
Processing 00000000.tx.358: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.359: 274, 11914-11923[Abstract/Free FullText] 12. 

Phrase: "274,"

Phrase: "11914-11923"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.360: Hardy, J. 

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.361: (1997) Trends Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.362: 20, 154-159[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "20,"

Phrase: "154-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.363: De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F. 

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.364: (1998) Nature 391, 387-390[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 391,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "387-390"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.365: Wolfe, M. 

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.366: S., Xia, W. 

Phrase: "S."

Phrase: ","

Phrase: "Xia,"

Phrase: "W."
Processing 00000000.tx.367: M., Ostaszewski, B. 

Phrase: "M."

Phrase: ","

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.368: L., Diehl, T. 

Phrase: "L., Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.369: S., Kimberly, W. 

Phrase: "S."

Phrase: ","

Phrase: "Kimberly,"

Phrase: "W."
Processing 00000000.tx.370: T., and Selkoe, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: (1999) Nature 398, 513-517[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "513-517"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.373: Steiner, H., Duff, K., Capell, A., Romig, H., Grim, M. 

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.374: G., Lincoln, S., Hardy, J., Yu, X., Picciano, M., Fechteler, K., Citron, M., Kopan, R., Pesold, B., Keck, S., Baader, M., Tomita, T., Iwatsubo, T., Baumeister, R., and Haass, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Picciano,"

Phrase: "M."

Phrase: ","

Phrase: "Fechteler,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Kopan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Keck,"

Phrase: "S."

Phrase: ","

Phrase: "Baader,"

Phrase: "M."

Phrase: ","

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Baumeister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.375: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.376: Biol. 

Phrase: "Biol."
Processing 00000000.tx.377: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.378: 274, 28669-28673[Abstract/Free FullText] 16. 

Phrase: "274,"

Phrase: "28669-28673"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.379: De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. 

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mumm,"

Phrase: "J."
Processing 00000000.tx.380: S., Schroeter, E. 

Phrase: "S."

Phrase: ","

Phrase: "Schroeter,"

Phrase: "E."
Processing 00000000.tx.381: H., Schrijvers, V., Wolfe, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schrijvers,"

Phrase: "V.,"

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: S., Ray, W. 

Phrase: "S."

Phrase: ","

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W."
Processing 00000000.tx.383: J., Goate, A., and Kopan, R. 

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kopan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: (1999) Nature 398, 518-522[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "518-522"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.385: Ye, Y. 

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Y."
Processing 00000000.tx.386: H., Lukinova, N., and Fortini, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lukinova,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Fortini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: E. 

Phrase: "E."
Processing 00000000.tx.388: (1999) Nature 398, 525-529[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "525-529"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.389: Struhl, G., and Greenwald, I. 

Phrase: "Struhl,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.390: (1999) Nature 398, 522-525[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "522-525"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.391: Naruse, S., Thinakaran, G., Luo, J. 

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "J."
Processing 00000000.tx.392: J., Kusiak, J. 

Phrase: "J.,"

Phrase: "Kusiak,"

Phrase: "J."
Processing 00000000.tx.393: W., Tomita, T., Iwatsubo, T., Qian, X. 

Phrase: "W., Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Qian,"

Phrase: "X."
Processing 00000000.tx.394: Z., Ginty, D. 

Phrase: "Z.,"

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.395: D., Price, D. 

Phrase: "D."

Phrase: ","

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.396: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.397: R., Wong, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wong,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.398: C., and Sisodia, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.399: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.400: (1998) Neuron 21, 1213-1221[Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 21,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1213-1221"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.401: Wolfe, M. 

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: S., Citron, M., Diehl, T. 

Phrase: "S."

Phrase: ","

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.403: S., Xia, W., Donkor, I. 

Phrase: "S."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Donkor,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.404: O., and Selkoe, D. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.405: J. 

Phrase: "J."
Processing 00000000.tx.406: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.407: Med. 

Phrase: "Med."
Processing 00000000.tx.408: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.409: 41, 6-9[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "41,"

Phrase: "6-9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442751:6 9 [Finding]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.410: Wolfe, M. 

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.411: S., Xia, W. 

Phrase: "S."

Phrase: ","

Phrase: "Xia,"

Phrase: "W."
Processing 00000000.tx.412: M., Moore, C. 

Phrase: "M."

Phrase: ","

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.413: L., Leatherwood, D. 

Phrase: "L., Leatherwood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0330617:Leatherwood [Plant]

Phrase: "D."
Processing 00000000.tx.414: D., Ostaszewski, B., Rahmati, T., Donkor, I. 

Phrase: "D."

Phrase: ","

Phrase: "Ostaszewski,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rahmati,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Donkor,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.415: O., and Selkoe, D. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.416: J. 

Phrase: "J."
Processing 00000000.tx.417: (1999) Biochemistry 38, 4720-4727[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4720-4727"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.418: Citron, M., Diehl, T. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.419: S., Gordon, G., Biere, A. 

Phrase: "S."

Phrase: ","

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.420: L., Seubert, P., and Selkoe, D. 

Phrase: "L., Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.421: J. 

Phrase: "J."
Processing 00000000.tx.422: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.423: Natl. 

Phrase: "Natl."
Processing 00000000.tx.424: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.425: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.426: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.427: 93, 13170-13175[Abstract/Free FullText] 23. 

Phrase: "93,"

Phrase: "13170-13175"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.428: Higaki, J. 

Phrase: "Higaki,"

Phrase: "J."
Processing 00000000.tx.429: N., Chakravarty, S., Bryant, C. 

Phrase: "N., Chakravarty,"

Phrase: "S."

Phrase: ","

Phrase: "Bryant,"

Phrase: "C."
Processing 00000000.tx.430: M., Cowart, L. 

Phrase: "M."

Phrase: ","

Phrase: "Cowart,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.431: R., Harden, P., Scardina, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Harden"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0702118:harden [Finding]
   944 E C0036429:Scleroses [Pathologic Function]

Phrase: ","

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Scardina,"

Phrase: "J."
Processing 00000000.tx.432: M., Mavunkel, B., Luedtke, G. 

Phrase: "M."

Phrase: ","

Phrase: "Mavunkel,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Luedtke,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.433: R., and Cordell, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Cordell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.434: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.435: Med. 

Phrase: "Med."
Processing 00000000.tx.436: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.437: 42, 3889-3898[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "42,"

Phrase: "3889-3898"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.438: Klafki, H., Abramowski, D., Swoboda, R., Paganetti, P. 

Phrase: "Klafki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Swoboda,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paganetti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.439: A., and Staufenbiel, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Staufenbiel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.441: Biol. 

Phrase: "Biol."
Processing 00000000.tx.442: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.443: 271, 28655-28659[Abstract/Free FullText] 25. 

Phrase: "271,"

Phrase: "28655-28659"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.444: Haass, C., and De Strooper, B. 

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.445: (1999) Science 286, 916-919[Abstract/Free FullText] 26. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "916-919"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.446: Wang, R., Sweeney, D., Gandy, S. 

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sweeney,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0270811:Sweeney [Disease or Syndrome]

Phrase: "D."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.447: E., and Sisodia, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.449: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.450: Biol. 

Phrase: "Biol."
Processing 00000000.tx.451: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.452: 271, 31894-31902[Abstract/Free FullText] 27. 

Phrase: "271,"

Phrase: "31894-31902"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.453: Thinakaran, G., Borchelt, D. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.454: R., Lee, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: K., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.456: H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spitzer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.457: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.458: E., Jenkins, N. 

Phrase: "E.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.459: A., Copeland, N. 

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.460: G., Price, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.461: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.462: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.463: (1996) Neuron 17, 181-190[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.464: Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "D."
Processing 00000000.tx.465: M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., St George-Hyslop, P. 

Phrase: "M."

Phrase: ","

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "D."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: H., and Fraser, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.467: E. 

Phrase: "E."
Processing 00000000.tx.468: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.469: Biol. 

Phrase: "Biol."
Processing 00000000.tx.470: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.471: 273, 16470-16475[Abstract/Free FullText] 29. 

Phrase: "273,"

Phrase: "16470-16475"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.472: Capell, A., Saffrich, R., Olivo, J. 

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Saffrich,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Olivo,"

Phrase: "J."
Processing 00000000.tx.473: C., Meyn, L., Walter, J., Grunberg, J., Mathews, P., Nixon, R., Dotti, C., and Haass, C. 

Phrase: "C., Meyn,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Mathews,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nixon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dotti,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.474: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.475: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.476: 69, 2432-2440[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "2432-2440"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.477: Palacino, J. 

Phrase: "Palacino,"

Phrase: "J."
Processing 00000000.tx.478: J., Berechid, B. 

Phrase: "J.,"

Phrase: "Berechid,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.479: E., Alexander, P., Eckman, C., Younkin, S., Nye, J. 

Phrase: "E.,"

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Nye,"

Phrase: "J."
Processing 00000000.tx.480: S., and Wolozin, B. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.481: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.482: Biol. 

Phrase: "Biol."
Processing 00000000.tx.483: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.484: 275, 215-222[Abstract/Free FullText] 31. 

Phrase: "275,"

Phrase: "215-222"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.485: Shin, J. 

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "J."
Processing 00000000.tx.486: E., Koh, J. 

Phrase: "E.,"

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.487: Y., and Mook-Jung, I. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Mook-Jung,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.488: (1999) Neurosci. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.489: Lett. 

Phrase: "Lett."
Processing 00000000.tx.490: 269, 99-102[CrossRef][Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "269,"

Phrase: "99-102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.491: Vestling, M., Cedazo-Minguez, A., Adem, A., Wiehager, B., Racchi, M., Lannfelt, L., and Cowburn, R. 

Phrase: "Vestling,"

Phrase: "M."

Phrase: ","

Phrase: "Cedazo-Minguez,"

Phrase: "A.,"

Phrase: "Adem,"

Phrase: "A.,"

Phrase: "Wiehager,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Racchi,"

Phrase: "M."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.492: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.493: (1999) Biochim. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.494: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.495: Acta 1453, 341-350[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "Acta 1453,"

Phrase: "341-350"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.496: Steiner, H., Romig, H., Grim, M. 

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.497: G., Philipp, U., Pesold, B., Citron, M., Baumeister, R., and Haass, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Philipp,"

Phrase: "U.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Baumeister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.498: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.499: Biol. 

Phrase: "Biol."
Processing 00000000.tx.500: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.501: 274, 7615-7618[Abstract/Free FullText] 34. 

Phrase: "274,"

Phrase: "7615-7618"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.502: Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., Huylebroeck, D., Zwijsen, A., Van Leuven, F., and De Strooper, B. 

Phrase: "Herreman,"

Phrase: "A.,"

Phrase: "Hartmann,"

Phrase: "D."

Phrase: ","

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Serneels,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Umans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Schrijvers,"

Phrase: "V.,"

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baekelandt,"

Phrase: "V.,"

Phrase: "Dressel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Huylebroeck,"

Phrase: "D."

Phrase: ","

Phrase: "Zwijsen,"

Phrase: "A.,"

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.503: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.504: Natl. 

Phrase: "Natl."
Processing 00000000.tx.505: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.506: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.507: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.508: 96, 11872-11877[Abstract/Free FullText] 35. 

Phrase: "96,"

Phrase: "11872-11877"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.509: Xia, W., Zhang, J., Perez, R., Koo, E. 

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Perez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.510: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.511: J. 

Phrase: "J."
Processing 00000000.tx.512: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.513: Natl. 

Phrase: "Natl."
Processing 00000000.tx.514: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.515: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.516: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.517: 94, 8208-8213[Abstract/Free FullText] 36. 

Phrase: "94,"

Phrase: "8208-8213"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.518: Thinakaran, G., Regard, J. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Regard,"

Phrase: "J."
Processing 00000000.tx.519: B., Bouton, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bouton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206181:bouton [Cell Component]

Phrase: "C."
Processing 00000000.tx.520: M., Harris, C. 

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "C."
Processing 00000000.tx.521: L., Price, D. 

Phrase: "L., Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.522: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.523: R., and Sisodia, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.525: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.526: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.527: 4, 438-453[CrossRef][Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "4,"

Phrase: "438-453"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.528: Xia, W. 

Phrase: "Xia,"

Phrase: "W."
Processing 00000000.tx.529: M., Zhang, J. 

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "J."
Processing 00000000.tx.530: M., Ostaszewski, B. 

Phrase: "M."

Phrase: ","

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.531: L., Kimberly, W. 

Phrase: "L., Kimberly,"

Phrase: "W."
Processing 00000000.tx.532: T., Seubert, P., Koo, E. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.533: H., Shen, J., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shen,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.534: J. 

Phrase: "J."
Processing 00000000.tx.535: (1998) Biochemistry 37, 16465-16471[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "16465-16471"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.536: Murayama, M., Tanaka, S., Palacino, J., Murayama, O., Honda, T., Sun, X. 

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "S."

Phrase: ","

Phrase: "Palacino,"

Phrase: "J.,"

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X."
Processing 00000000.tx.537: Y., Yasutake, K., Nihonmatsu, N., Wolozin, B., and Takashima, A. 

Phrase: "Y.,"

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.538: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.539: 433, 73-77[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "433,"

Phrase: "73-77"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.540: Zhang, Z., Hartmann, H., Do, V. 

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Hartmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Do"

Phrase: ","

Phrase: "V."
Processing 00000000.tx.541: M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., De Strooper, B., He, X., and Yankner, B. 

Phrase: "M."

Phrase: ","

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "Sommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "van de Wetering,"

Phrase: "M."

Phrase: ","

Phrase: "Clevers,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "He,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.542: A. 

Phrase: "A."
Processing 00000000.tx.543: (1998) Nature 395, 698-702[CrossRef][Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "698-702"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.544: Zhou, J., Liyanage, U., Medina, M., Ho, C., Simmons, A. 

Phrase: "Zhou,"

Phrase: "J.,"

Phrase: "Liyanage,"

Phrase: "U.,"

Phrase: "Medina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2767010:Medina [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Simmons,"

Phrase: "A."
Processing 00000000.tx.545: D., Lovett, M., and Kosik, K. 

Phrase: "D."

Phrase: ","

Phrase: "Lovett,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.546: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.547: (1997) Neuroreport 8, 2085-2090[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuroreport 8,"

Phrase: "2085-2090"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.548: Kang, D. 

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.549: E., Soriano, S., Frosch, M. 

Phrase: "E.,"

Phrase: "Soriano,"

Phrase: "S."

Phrase: ","

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.550: P., Collins, T., Naruse, S., Sisodia, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Collins,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.551: S., Leibowitz, G., Levine, F., and Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Leibowitz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Levine,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.552: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.553: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.554: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.555: 19, 4229-4237[Abstract/Free FullText] 42. 

Phrase: "19,"

Phrase: "4229-4237"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.556: Passer, B. 

Phrase: "Passer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0491928:PASSER [Medical Device]
  1000   C0999347:Passer [Bird]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.557: J., Pellegrini, L., Vito, P., Ganjei, J. 

Phrase: "J.,"

Phrase: "Pellegrini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ganjei,"

Phrase: "J."
Processing 00000000.tx.558: K., and D'Adamio, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.559: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.560: Biol. 

Phrase: "Biol."
Processing 00000000.tx.561: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.562: 274, 24007-24013[Abstract/Free FullText] 43. 

Phrase: "274,"

Phrase: "24007-24013"

Phrase: "[Abstract/Free FullText"

Phrase: "] 43."
Processing 00000000.tx.563: Wong, P. 

Phrase: "Wong,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.564: C., Zheng, H., Chen, H., Becher, M. 

Phrase: "C., Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Becher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.565: W., Sirinathsinghji, D. 

Phrase: "W., Sirinathsinghji,"

Phrase: "D."
Processing 00000000.tx.566: J., Trumbauer, M. 

Phrase: "J.,"

Phrase: "Trumbauer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.567: E., Chen, H. 

Phrase: "E.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.568: Y., Price, D. 

Phrase: "Y.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.569: L., Van der Ploeg, L. 

Phrase: "L., Van der Ploeg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557775:Van [Manufactured Object]
   812   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.570: H., and Sisodia, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.571: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.572: (1997) Nature 387, 288-292[CrossRef][Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 387,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "288-292"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.573: Ray, W. 

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W."
Processing 00000000.tx.574: J., Yao, M., Mumm, J., Schroeter, E. 

Phrase: "J.,"

Phrase: "Yao,"

Phrase: "M."

Phrase: ","

Phrase: "Mumm,"

Phrase: "J.,"

Phrase: "Schroeter,"

Phrase: "E."
Processing 00000000.tx.575: H., Saftig, P., Wolfe, M., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.576: J., Kopan, R., and Goate, A. 

Phrase: "J.,"

Phrase: "Kopan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.577: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.578: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.579: Biol. 

Phrase: "Biol."
Processing 00000000.tx.580: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.581: 274, 36801-36807[Abstract/Free FullText] 45. 

Phrase: "274,"

Phrase: "36801-36807"

Phrase: "[Abstract/Free FullText"

Phrase: "] 45."
Processing 00000000.tx.582: Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. 

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kohno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sugihara,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.583: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.584: Natl. 

Phrase: "Natl."
Processing 00000000.tx.585: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.586: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.587: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.588: 95, 9637-9641[Abstract/Free FullText] 46. 

Phrase: "95,"

Phrase: "9637-9641"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.589: Scheper, W., Zwart, R., van der Sluijs, P., Annaert, W., van Gool, W. 

Phrase: "Scheper,"

Phrase: "W.,"

Phrase: "Zwart,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "van der Sluijs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "van Gool,"

Phrase: "W."
Processing 00000000.tx.590: A., and Baas, F. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Baas,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.591: (2000) Hum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.592: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.593: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.594: 9, 303-310[Abstract/Free FullText] 47. 

Phrase: "9,"

Phrase: "303-310"

Phrase: "[Abstract/Free FullText"

Phrase: "] 47."
Processing 00000000.tx.595: Georgakopoulos, A., Marambaud, P., Efthimiopoulos, S., Shioi, J., Cui, W., Li, H. 

Phrase: "Georgakopoulos,"

Phrase: "A.,"

Phrase: "Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Efthimiopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Cui,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707476:CUI [Intellectual Product]
  1000   C2348662:CUI [Intellectual Product]

Phrase: "W.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.596: C., Schutte, M., Gordon, R., Holstein, G. 

Phrase: "C., Schutte,"

Phrase: "M."

Phrase: ","

Phrase: "Gordon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Holstein,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.597: R., Martinelli, G., Mehta, P., Friedrich, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Martinelli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mehta,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Friedrich,"

Phrase: "V."
Processing 00000000.tx.598: L., Jr., and Robakis, N. 

Phrase: "L., Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.599: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.600: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.601: Cell 4, 893-902[Medline] [OrderarticleviaInfotrieve] 48. 

Phrase: "Cell 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "893-902"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 48."
Processing 00000000.tx.602: Katayama, T., Imaizumi, K., Sato, N., Miyoshi, K., Kudo, T., Hitomi, J., Morihara, T., Yoneda, T., Gomi, F., Mori, Y., Nakano, Y., Takeda, J., Tsuda, T., Itoyama, Y., Murayama, O., Takashima, A., St George-Hyslop, P., Takeda, M., and Tohyama, M. 

Phrase: "Katayama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Imaizumi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sato,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Miyoshi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kudo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hitomi,"

Phrase: "J.,"

Phrase: "Morihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoneda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gomi,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mori,"

Phrase: "Y.,"

Phrase: "Nakano,"

Phrase: "Y.,"

Phrase: "Takeda,"

Phrase: "J.,"

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Itoyama,"

Phrase: "Y.,"

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Takeda,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tohyama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.603: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.604: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.605: 1, 479-485[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "479-485"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.606: Niwa, M., Sidrauski, C., Kaufman, R. 

Phrase: "Niwa,"

Phrase: "M."

Phrase: ","

Phrase: "Sidrauski,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kaufman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.607: J., and Walter, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Walter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.608: (1999) Cell 99, 691-702[Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell 99,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "691-702"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.609: Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.-"

Phrase: "M."

Phrase: ","

Phrase: "Xu,"

Phrase: "M."

Phrase: ","

Phrase: "Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "M.-T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huang,"

Phrase: "Q.,"

Phrase: "Castro,"

Phrase: "J."
Processing 00000000.tx.610: L., Dimuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. 

Phrase: "L., Dimuzio-Mower,"

Phrase: "J.,"

Phrase: "Harrison,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lellis,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nadin,"

Phrase: "A.,"

Phrase: "Neduvelil,"

Phrase: "J."
Processing 00000000.tx.611: G., Register, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Register,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.612: B., Sardana, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Sardana,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.613: K., Shearman, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shearman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.614: S., Smith, A. 

Phrase: "S."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.615: L., Shi, X.-P., Yin, K.-C., Shafer, J. 

Phrase: "L., Shi,"

Phrase: "X.-P.,"

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "K.-C., Shafer,"

Phrase: "J."
Processing 00000000.tx.616: A., and Gardell, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Gardell,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.617: J. 

Phrase: "J."
Processing 00000000.tx.618: (2000) Nature 405, 689-694[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 405,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "689-694"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

